Qualitative and quantitative assessment of patient counseling occurring in a section of Gauteng's community pharmacies by Mukandabarasa, Monique Rwabuhungu
UNIVERSITY OF THE WITWATERSRAND, 
JOHANNESBURG 
FACULTY OF HEALTH SCIENCES 
 
 
 
 
 
 
 
 
 
QUALITATIVE AND QUANTITATIVE ASSESSMENT OF 
PATIENT COUNSELING OCCURRING IN A SECTION OF 
GAUTENG’S COMMUNITY PHARMACIES 
 
 
Monique Rwabuhungu Mukandabarasa 
(Bachelor of Pharmacy) 
 
 
 
A research report submitted to the faculty of Health sciences, University 
of the Witwatersrand, Johannesburg, in partial fulfillment of 
requirements for the degree of Masters of Science in Medicine 
(Pharmaceutical Affairs) 
 
 
 
 
Johannesburg, 2007 
  
 
i
DECLARATION 
 
I, Monique Rwabuhungu Mukandabarasa, declare that this research report is 
my own work. It is being submitted for the Degree of Masters of Science in 
Medicine (Pharmaceutical Affairs) at the University of the Witwatersrand, 
Johannesburg. It has not been submitted before for any degree or 
examination at this or any other University. 
 
 
Signature of candidate…………………………… 
 
 
On this ………..day of ………… 2007 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
ii
 
DEDICATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
To God for sparing my life to see the completion of this research report 
  
 
iii 
 ABSTRACT 
This study intended to assess the nature and extent of patient counseling practice in a 
section of Gauteng’s community pharmacies and determine what factors have negative 
impact on the practice. Designed as a random cross-sectional survey, questionnaire-based 
engaging 60 pharmacists and 179 customers, it provided a “snapshot” of counseling 
services in the Johannesburg and Pretoria regions between January 2006 and September 
2006. The outcomes measures assessed included the percentage of the actual practicing, 
the form of communication, number of items covered, and number of counseling steps 
accomplished.  
 
The findings showed about 74% of patients received at least one drug informational item 
as verbal advice, and an average of 62% of patients received six drug informational items 
of advice. Supplementary written information was given to 56% of patients some of the 
time when necessary or by request. The items of advice achieved at high rate were all 
about drug-instructions for use (>70%). Information about drug action, side effects and 
non-pharmacological advice occurred at low rate (<50). Significant difference (p<0.05) 
was observed between the two regions regarding the accomplishment of some items but 
no difference was noted referring to global counseling performance. Younger pharmacists 
overtook older pharmacists in performing some items (like telling when the medication 
begins to work: 53% versus 37%). Differences were also noted between pharmacists and 
other categories of dispensers with pharmacists proffering a higher level of quality and 
quantity of advice (e.g. counseling points summarized: 59% versus 30%). Workload, 
pharmacy type and gender were unrelated to current counseling practice.   
 
In conclusion, participating pharmacists showed good knowledge of the SA Gold 
Standard on counseling and satisfactory performed the counseling points. However, some 
expressed concern about the difficulty to accomplish some special GPP provisions. 
Future studies are advice to investigate the implementation of patient counseling from a 
nationwide sample of community pharmacies if the Professional Body regulating 
Pharmacy intends mandating counseling. 
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GLOSSARY OF TERMINOLOGY 
 
Adherence: is used instead of compliance and refers to whether or not patients take their 
medication as prescribed. It encompasses the patient’s active participation in his or her 
own healthcare, seeking medical advice, keeping appointments, following 
recommendations concerning lifestyle, as well as following medical regimens. 
Medication non-adherence is most simply defined as the number of doses not taken or 
taken incorrectly that jeopardizes the patient’s therapeutic outcome. Myers and Midence 
(1998) consider it to be a ‘more neutral, less judgmental term’ while Leventhal (1992) 
says ‘it importantly represents a conceptual shift away from patient obedience towards 
empowering in their health decisions’. The use of the term adherence is more respectful 
of the important role that a patient plays in the process.  
 
Compliance: from (http://www.uams.edv/compliance/define.htm ), on reads ‘it is the 
extent to which a person’s behaviour (in term of taking medications, following diets, or 
executing lifestyle changes) coincides with medical or health advice. In keeping with the 
medical circumstances, patients should do what they are told by a health professional. 
This implies that the advice and directions given to the patient are always correct, 
because the diagnosis and treatment are appropriate, and the prescribed regimen is 
understandable and achievable.’  
 
Medication: is a drug or another form of medicine that is taken to prevent or to treat an 
illness. 
 
Medicines consultation: some researchers have questioned if the term counseling can be 
used to describe the information exchange between pharmacists and customers in the 
context of community pharmacy (Raynor 1996, Pilnick 2003). According to these 
researchers, ‘what pharmacists mean by counseling is the imparting of information as a 
one-way process.’ In addition, Vainio (2004) pointed out that ‘in practice, counseling 
usually involves repeating verbally the information on the medicine label and giving 
instructions for complying with drug therapy regimens.’  Therefore, Raynor (1996) 
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suggested the term concerning advice and explanation about medicines should instead be 
called medicines consultation. 
 
Patient Advice: has been referred to as the transfer of information and advice about 
recommended actions from the pharmacist to an individual patient or customer. 
According to Blenkinsopp et al. (1999), ‘ideally, advice-giving should be two-way 
interactive process, where the person is invited to respond and to seek further information 
should they need it. Advice-giving should be for the specific purpose of enabling the 
patient or caregiver to cooperate in his or her own care to fullest possible extent under the 
circumstances.’ 
 
Patient counseling: is the provision of advice from the practitioner relating to the drug 
product that will help patients to use their medications properly. Schommer and 
Wiederholt (1995) defined the term as ‘the provision of verbal or written information 
(including auxiliary labels) that is the reasoned opinion of a pharmacist, is subjective, and 
is patient-oriented within a medication-taking context.’ 
 
Patient education: ‘is instruction and development to impart skills and knowledge, to 
cause a progressive change in attitudes, behaviour and knowledge of patient (ASHP 
guidelines 1997).’ In the context of pharmacy, the term patient education is used 
interchangeably with patient counseling. 
 
Pharmaceutical Care: is a new concept introduced in pharmacy practice in 1990s. The 
goal of pharmaceutical care is the responsible provision of drug therapy to achieve 
definite outcomes intended to improve a patient’s quality of life. With reference to Hepler 
(1997), this requires a drug therapy system ‘directed toward people’s quality of life’, and 
one necessary element of such a system is ‘dispensing and patient advice’. 
 
Pseudo customer: is a person trained to play the role of a patient to assess whether and 
how a drug dispenser shall advise about the medication handed to the patient. The term 
has the similar meaning with mystery shopper (Berger and Eickhoff 2005).  
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1 INTRODUCTION AND BACKGROUND INFORMATION 
 
 
1.1 INTRODUCTION 
 
Health care professionals are accepted as a valid source of health information, and their 
attitudes and counseling practices have a meaningful impact on the health habits of their 
patients.  
 
Pharmacists as health professionals should therefore focus comprehensively on the 
pharmaceutical needs of their patients. In the past, the primary function of a pharmacist 
was to compound and dispense medicines prescribed by physicians, dentists, or other 
authorized health care providers. In recent years, however, the responsibilities of 
pharmacists have broadened substantially, primarily in the areas of direct patient care, 
patient education and multidisciplinary care initiatives. These activities are called 
“cognitive services”, “pharmaceutical care” or “medication therapy management” 
according to the different authors (Morgall et al 1999, Ritchery et al. 1993, Sleath and 
Campbell 1998). Regardless of the diversity of terms used, a number of studies have 
shown that effective patient counseling or advice significantly reduce non-adherence, 
treatment failure, drug hazards and wasted health resources. Provided with the necessary 
knowledge patients will be empowered to direct their own course to good health. 
 
Patient counseling is essentially about providing patients with accurate information and 
guidance on their medicines. This process has been identified as crucial in assisting 
patients to correctly take their medication; thereby resulting in obtaining optimal 
therapeutic outcomes with less or no side effects (Nichol and Michael 1992; Scott and 
Wessels 1997; Svarstad et al.2004). With regard to this basic element of patient’s health 
care, pharmacists have been positioned as key role-players, either in hospitals or in 
community pharmacies. This implies the pharmacist must, at the hospital level, ensure 
patients are, before leaving the hospital, aware of what medication they have been 
prescribed, how to take the medication, what the medication is for, what to expect from 
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the medication, possible side effects, what to avoid such as sunlight or certain foods, and 
necessary lifestyle changes such as diet.  
 
However, King et al (1998) found in USA, one out of four patients leave the hospital 
without knowing what a newly prescribed medication is for and how to administer that 
medication. They also observed patients discharged from the hospital with three or more 
newly prescribed drugs have difficulty recalling the basics of their new prescription. 
Paulino et al. (2004) reported similar problems in the European community. It means the 
critical point in patient counseling is actually when the patient is discharged into the 
community. The responsibility for counseling the patient on how to use the drug then 
falls on the retail pharmacists operating in the communities. 
 
To enforce the pharmacist’s responsibility in pharmaceutical care initiatives, new 
coercive laws have been passed through pharmaceutical legislation in different countries 
and these compel dispenser pharmacists to offer proper counseling and pharmaceutical 
services to patients. To accurately prepare pharmacy students towards the 
accomplishment of this task, pharmacy schools worldwide have also introduced relevant 
courses in their training curricula including communication skills, pharmaceutical care 
processes, medication management programmes and physical assessment skills. 
 
The impact of mandatory state regulations and implementation of pharmacy practice 
courses in lifting the level of counseling practice is unquestionable. Published surveys on 
the matter indicate however, that the actual level of achievement remains under the 
expectation in some cases. Various factors, such as pharmacist’s attitudes and norms, 
workload, pharmacy type and stringency of state regulations, have been associated with 
this deviation from the expected practice. 
 
This study has been undertaken to clarify the extent of patient counseling services in 
community pharmacies in South Africa, and to identify barriers to implementation of the 
pharmaceutical care processes endorsed by regulations and undergraduate training. 
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1.2 BACKGROUND INFORMATION 
 
 
South Africa introduced its first Medicines Act in 1965 known as -The Medicines Act 
101 of 1965; approximately ten years later, -The Pharmacy Act 53 of 1974 was released. 
The Pharmacy Act 53 of 1974 states ‘as part of the scope of practice of a pharmacist, 
furnishing of information and advice to any patient with regard to the use of medicine 
needs to be undertaken, and in order for this to occur, pharmacists need to understand the 
importance of counseling and what it entails.’ Since 1996, the SA Good Pharmacy 
Practice (SA GPP) and the National Drug Policy of Safety Drug Use (NDP 1996) 
reinforced the importance of health counseling. The SA GPP emphasizes that a 
pharmacist must counsel each patient’s caregiver on matters, which will optimize the 
medical therapy prescribed. The NDP underlines one can improve health and enhance the 
outcome of medical treatment by empowering patients to make informed decisions about 
their medical treatments and take responsibility for their own care. In addition, South 
African legislation and professional code of conduct reinforce the role of pharmacist 
more as simple dispenser. 
 
At the academic level, South Africa has a long tradition of pharmaceutical teaching and 
training since the 1950s. In 1970, the Rhodes University faculty of pharmacy undertook a 
major revision, involving the extension of the academic course to four years with a one-
year apprenticeship at the end of the academic course (www.ru.co.za/Annual Review, 
2003). Followed by one year structured internship and an additional year of remunerated 
community service in the public sector to increase the competency of the new 
pharmacists, entry level pharmacists are therefore able to act properly with confidence, in 
the particular area of patient counseling. This has been adopted by all pharmacy schools 
in SA. Today, in every SA University offering pharmacy programme, a course on 
Pharmacy Practice is included in the experiential learning curriculum (Kairuz and Naidoo 
2000). Pharmacy Practice involves teaching the practical applications, legal and ethical 
aspects, marketing and business skills, and encompasses pharmacy specific science such 
as drug supply management, Pharmacoepidemiology, Pharmacovigilance and so on.  
  
 
4
Despite this stringent theoretical initiative, little is known about the implementation of 
patient counseling by pharmacists as health care professionals in South Africa. The 
current nature and extent of patient counseling in the country is not well documented.  
 
Rhodes University students addressed the issue in 1998 by measuring three variables: [1] 
Behaviour-identifying the frequency with which each task was carried out; [2] Attitude-
rating the perceived importance of each task and [3] Practicality-rating the ease/difficulty 
of carrying out each task. Based on the results obtained, the investigators stated the GPP 
guidelines were a starting point but continuing education programmes are necessary to 
ensure pharmacists comprehend the importance and have the competence to carry them 
out. They also stated it was vital to ensure pharmacists have a positive attitude and 
perceive the need to change (Flutter 1998). 
 
Burroughs et al (2004) pointed out ‘communication and counseling could be challenging 
in a multicultural society. South African pharmacists and their patients come from 
diverse cultural backgrounds, which can affect their perception of health and medication 
use and how they communicate. Understanding ethnicity and culture can be therefore 
useful in communication and counseling even though it cannot always accurately predict 
individual behaviour and should not be used to limit options for diagnosis and treatment.’ 
 
The scarcity of data shows it remains necessary to conduct investigations aimed at 
measuring the current nature and extent of counseling practice to monitor the level of 
pharmacists’ compliance with pharmacy council regulations and measure the actual 
impact of academic changes. The interventions would also allow identification of factors 
that may impede satisfactory counseling practice. 
 
The anticipated hypothesis for this study was that SA GPP requirements and academic 
changes have had a positive impact on patient counseling although the performance may 
be subjective to some demographic factors. 
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1.3 STUDY OBJECTIVES 
 
In conceptualizing this research, the following sub-questions were used as guidelines: 
 
1 What is the format of information given to patients in community pharmacies 
(written form as a printed label, handwritten label, instruction written on the packet, 
or verbal advice)? 
2 What is the prevalence of effective verbal counseling? 
3 What is the impact of pharmacy and pharmacist- related factors on the prevalence 
of patient counseling? 
4 Are the national standard scenarios on counseling sufficient and well known by the 
pharmacists? 
5 What kind of assessment-tools do pharmacists need to evaluate and improve the 
quality of their performance? 
6 What would be pragmatic patient-counseling guidelines for community pharmacies 
in South Africa? 
 
To answer to these questions, four specific objectives emerged: 
 
1. To test the acceptability and feasibility of self-assessment by the community 
pharmacists in their daily routine. 
2. To develop a self-assessment-tool for community pharmacists to evaluate and 
improve the quality of their performance. 
3. To assess the nature and extent of patient counseling in the current environment of 
community pharmacies. 
4. To identify factors that may influence counseling with respect to the dispenser’s 
demographics (age, gender, qualification) and pharmacy characteristics such as 
location, type and level of activities. 
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2 LITERATURE REVIEW 
 
This section describes the main GPP guidelines concerning the pharmaceutical care that 
directed the construction of the assessment tools and reviews the key similar studies 
about counseling. 
 
 
2.1 GPP STANDARDS OF PHARMACIST – PATIENT COMMUNICATION 
 
 
The following lines briefly browse the role of the pharmacist, the general GPP 
requirements as well as the standards of practice. These standards excerpted from WHO 
GUIDELINES (www.fip.org/fip/statements) have been found useful in USA 
(www.napra.org/pdfs/provinces/pe). This study is going to figure out the extent to which 
similar comprehensive guidelines are used in South Africa to strengthen the counseling 
role of the community pharmacists. In essence, the mission of pharmacy practice is to 
provide medications and other health care products and services and help people and the 
society to make the best use of them. All practicing pharmacists are obliged to ensure that 
the service they provide to every patient is of appropriate quality and Good Pharmacy 
Practice is a means of clarifying and meeting that obligation.  
2.1.1 The pharmacist’s roles  
 
The WHO Consultancy Group summarized the roles of a Pharmacist into the concept of 
“the seven stars pharmacist” (WHO/PHARM 1997). In this concept, “communicator” is 
in third position: 
 
1. Care giver -the pharmacist provides caring services. 
2. Decision maker -the appropriate, efficacious and cost effective use of resources. 
3. Communicator - the pharmacist is in ideal position between physician and patient. 
4. Leader -whether the pharmacist finds him/herself in a multidisciplinary team. 
5. Manager -the pharmacist must effectively, manage resources (human, physical and 
fiscal) and information. 
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6. Life-long-learner -it is no longer possible to learn everything in school in order to 
practice a career as a pharmacist. 
7. Teacher -the pharmacist has a responsibility to assist with the education and 
training of future generations of pharmacists. 
 
From this concept, the general WHO GPP requirements urge pharmacists to focus all 
their interventions on the benefits of patients. The following are some of the basic 
guidelines (PEIPB 2005): 
 
• A pharmacist’s first concern in all settings is the welfare of the patients; 
• The core of pharmacy activity is the supply of medication and other health care 
products of assured quality, appropriate information and advice for the patient, and 
monitoring of the effects of use; 
• An integral part of the pharmacist’s contribution is the promotion of rational and 
economic prescribing of appropriate use of medicines; 
• The objective of each element of pharmacy service is relevant to the patient, is 
clearly defined and is effectively communicated to all those involved. 
 
In South Africa, the unit standards for competencies of entry-level pharmacists proposed 
by the South African Council (Kairuz and Naidoo, 2000) are: 
 
- Organise and control the manufacturing, compounding and packaging of 
pharmaceutical products; 
- Organise the procurement, storage and distribution of pharmaceutical materials and 
products; 
- Dispense and ensure the optimal use of medicines prescribed to the patient; 
- Provide pharmacist initiated care to the patient and ensure the optimal use of 
medicine; 
- Provide education and information on health care and medicine; 
- Promote community health and provide related information and advice; 
- Participate in research to ensure the optimal use of medicine. 
  
 
8
2.1.2 Standards of Practice 
 
The items set up as outcomes measures refer to the standards (PEIPB 2005) related to 
drug information the pharmacist is required to provide the patient with and counseling 
process steps to run  up. 
 
2.1.2.1  What and How to counsel? 
 
The standards require each pharmacist to develop, implement and fulfil plans to monitor 
the patient’s progress towards desired therapy. For this, she or he will routinely and 
accurately identify the amount and type of education desired or required by patients to 
maximize their chances of solving or preventing their drug related problem(s). The 
pharmacist must also routinely and accurately identify the degree of monitoring required 
by a patient according to the health risks posed by the patient’s medication, drug related 
problems, or disease. In consideration of the above two statements, WHO GPP standards 
incite pharmacists to appropriately advise and educate patients on the following when 
dispensing prescription and non-prescription drugs, when counseling patient on discharge 
medications or when providing recommendations about the management of specific drug 
related problems: 
 
• Name and class of the drug (e.g. antibiotic, pain reliever); 
• Directions for use including education about devices; 
• Special storage requirements; 
• Common or important drug-interactions; 
• The reason and the intended therapeutic response and associated time frames; 
• Common or important side effects and associated time frames; 
• What the patient should do to monitor his/her therapeutic response or development 
of side effects; 
• Actions the patient should take if the intended therapeutic response is not obtained 
or side effects develop; 
• When appropriate, the actions the pharmacist will undertake to monitor the patient’s 
progress. 
  
 
9
Concerning the counseling process, WHO GPP requirements underline the pharmacist-
patient interaction has to be friendly and conducted on a one-to-one basis 
(www.fip.org/fip/statements). A standard checklist of counseling encompasses the 
following steps: 
 
1. Establish relationship - show interest in patient (verbal and non-verbal); 
2. Verify patient’s name and prescriber’s name; 
3. Why the medication is being prescribed (if known) or the medication’s use; 
expected benefits and action; 
4. Open the medication packaging and show patient what the medication looks like, or 
demonstrate use; 
5. Do actual counseling e.g.; 
- How to take the medication, 
- When to take and how long to take the medication, 
- What to do if a dose is missed, 
- Any special precautions: foods, alcoholic beverages or OTCs to be avoided, 
- How the patient will know the medication is working, 
- How to store the medication, 
- If the prescription can be refilled, and if so, when; 
6. Verify the patient’s knowledge and understanding; 
7. Ask the patient if they have any questions; 
8. Document the interaction. 
 
Some of these items have been included in the outcome-measures in the investigational 
questionnaires. 
 
2.1.2.2 Who and When to counsel? 
 
About prescribed medicines: 
Since not all patients are in the same situation, the amount and type of information 
provided to them should vary based on the patient’s needs and practice setting. Ideally, 
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the pharmacist counsels patients on all new and refill prescriptions. However, if the 
pharmacist cannot counsel to this extent, it should be defined which patient types, or with 
which medications the pharmacist will routinely counsel. This will vary depending on the 
pharmacy clientele and may include: 
 
- Patients receiving more than a specified number of medications; 
- Patients known to have visual, hearing or literacy problems; 
- Paediatric patients; 
- Patients on anticoagulants. 
 
The WHO GPP standards define which patients should always be counseled and which 
patients only occasionally. 
 
Patients who should always be counseled are: 
- Confused patients, and their caregivers; 
- Patients who are sight or hearing impaired; 
- Patients with poor literacy; 
- Patients whose profile shows a change in medications or dosing; 
- New patients or those receiving a medication for the first time (transfer 
prescription); 
- Children and parents receiving medication; 
- Patients receiving medication with special storage requirements, complicated 
directions, and significant side effects have to be well counseled. 
 
Patients who should be counseled at certain intervals are: 
- Asthmatic patients; 
- Diabetic patients; 
- Epileptic patients; 
- Patients who are mentally ill; 
- Patients with skin complaints;  
- Patients taking four or more prescribed medications; 
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- Patients using medical appliances; 
- Patients misusing drugs; 
- Patients who are terminally ill. 
 
About OVER-THE-COUNTER (OTC) medication: 
When providing care to patients involving OTCs, it will be necessary to perform an 
adequate mini-assessment of the patient’s problem, consisting of their approximate age; 
inquiring about any current medical conditions; current non-prescription drug use; current 
prescription drug use; inquiring about the symptoms and duration of the complaint and 
whether the patient has any allergies. The pharmacist should ask whether the patient has 
consulted a health care professional about the problem. Before advice can be given, the 
pharmacist (or pharmacist intern or the pharmacist assistant) will need knowledge on the 
nature, severity and extenuating circumstances surrounding those symptoms.   
 
In essence, the pharmacist must try to obtain initial medication related information. When 
the pharmacist has assessed the patient and the problem, and feels that a referral is not 
necessary, he/she may recommend an appropriate product or course of action, including 
non-drug measures.  
 
2.1.2.3 When to refer or invite patient back? 
 
This issue is addressed by measuring whether the pharmacist tried to obtain initial drug 
information or whether the patient is invited back without distinction between OTC’s and 
prescribed medicines. The pharmacist should refer the patients for medical attention if: 
 
- Their condition is potentially severe; 
- They are uncertain about their symptoms; 
- Their self-diagnosis is likely incorrect; 
- The condition has not responded to previous appropriate therapy, or  
- They have other risk factors that should be assessed. 
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2.1.2.4 Format in which counseling will be provided 
 
With reference to WHO GPP, the format of counseling should be verbal, and 
accompanied by written material for the patient to refer to at home. The argument for 
written material is that patients are often stressed and upset about their illness while 
waiting for their prescription and may not be able to focus on what the pharmacist is 
discussing with them. Then, written material reinforces what the pharmacist advises and 
helps the patient recall what was said. Furthermore, if the patient has forgotten or is 
unsure of what the pharmacist said, the written material may provide the answer, or 
stimulate the patient to call the pharmacist.  
 
The written material may provide basic information only, or be quite detailed. 
Pictograms, such as those used for illustrating how to administer eye drops, are much 
easier to understand and should supplement a detailed verbal description. 
 
2.1.2.5 Counseling area and confidentiality  
 
On this matter, the patient should be counseled in a semi-private or private area away 
from other people and distractions, depending on the medication(s). The patient should 
perceive the counseling area as confidential, secure and conducive to learning. As 
stipulated in the standards, this helps to ensure that both parties are focused on the 
discussion, and minimizes interruptions and distractions. It provides an opportunity for 
patients to ask questions they may be hesitant to ask in public. 
 
In the present study, there is no specific assessment to evaluate the number of pharmacies 
providing an isolated area for counseling. A question addressing the impact of 
distractions (e.g. noise, telephone call…) is an indirect measure of the necessity to 
provide a pharmacy setting with special counseling area. 
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2.1.2.6 Documentation 
 
The study may show whether this process is applicable or needed in the current 
environment of SA community pharmacies. The counseling session should be 
documented. This may be as simple as a check list or as detailed as recorded notes in the 
patients’ medication profile. Any follow-up required should be noted. It should also be 
recorded if the patient does not wish to be counseled.  
 
2.2 REVIEW OF SIMILAR STUDIES IN DIFFERENT COUNTRIES  
 
The impact of coercive laws in USA: 
Programmes aiming to promote and implement pharmaceutical care in community 
pharmacies were run in the 1990s. Not only do standards of practice from major 
pharmaceutical professional organisations concur that patient counseling is an essential 
component of pharmaceutical care, but legal regulations such as the Omnibus Budget 
Reconciliation Act of 1990 (OBRA 90) mandate pharmacists to offer counseling to 
patients. The result of these programmes (e.g. Practice Enhancement Programme PEP, 
Project ImPACT) showed that pharmacists increased communication with patients and 
other health care professionals and the outcomes of drug therapies improved among 
targeted patient groups (Blumi et al. 2000; Kassam et al. 1999, Beardsley 2001). This 
study investigates if similar mandatory provisions are needed in SA. 
 
The nature and extent of counseling in USA community pharmacies: 
Svarstad et al. (2004) evaluated in different USA states the nature and extent of patient 
counseling as well as the effects of state regulation, pharmacist’s age and workload on 
patient counseling provided in community pharmacies. While the age of the responsible 
pharmacist had no effect on whether the patient talked with the pharmacist or received 
any verbal information, the pharmacist’s age was linked to other counseling measures. 
For instance, the authors observed patients with a younger responsible pharmacist were 
more likely to receive some risk information, a greater number of informational items per 
drug, and some assessment of understanding. Workload was unrelated to the total amount 
of verbal information or whether some risk information was provided. 
  
 
14
In designing the present study questionnaire, some questions were formulated to assess 
the impact of pharmacy’s characteristics and pharmacist’s demographics. South Africa is 
a Republic and not Federal State like USA, so the impact of state regulation is not 
assessed. Whether similarity or discrepancies exist between USA and SA Pharmacists’ 
behaviour will be highlighted. 
 
Patients’ perceptions of drug counseling in Israel: 
Shani et al. (2000) evaluated patients’ perceptions of drug counseling by health 
professionals - the prescribing physician and dispensing pharmacist - and determined 
whether a difference exists in the patient’s perception according to his or her place of 
birth and mother tongue. Their conclusion was ‘counseling by pharmacists is a common 
and well-accepted activity and occurs at a high rate (64.6% for any type of counseling).’  
 
Implementation of patient counseling in Germany: 
Berger et al (2005) evaluated the implementation of the pseudo customer methodology to 
assess the counseling quality in community pharmacies. A pseudo-customer is a trained 
mystery shopper acting as a patient. They found 98% of the participating pharmacies 
offered advice, but in 36% of the cases, advice was only given on request. Information on 
appropriate self-medication was provided on at least one item in 74% of pseudo customer 
visits, but most of the time the information was not sufficient.  Communication skills 
(non-verbal elements, comprehensibility etc.) were very good or good in 54% of the 
visits. The performance of this technique will be compared to the pharmacist-self 
assessment approach used in the present study. 
 
Continuing education and patient counseling:  
In Australia, a new technique that combined a pseudo customer methodology and 
continuing education was developed to change practice behaviour (De Almeida Neto et 
al. 2001). This training methodology uses the pseudo customer as a change mechanism to 
shape practice behaviour. The new concept starts with workshop training that is followed 
by pseudo customer visits. After the visits, participants are given immediate feedback and 
coaching from an experienced pharmacy educator. This methodology has been 
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successfully applied e.g. to pharmacists dealing with non-prescription analgesics in 
Australia and in Switzerland (De Almeida Neto et al. 2001, Sigrist et al. 2002). The 
results indicate that combining training with pseudo customer visits and immediate 
feedback supports the learning process and its sustainability. 
 
In the Netherlands, systematic educational intervention was designed to improve patient 
education activities undertaken by pharmacy technicians (Pronk 2002). The intervention 
included course work and on-the job training. The participants carried out an inventory of 
existing practices in their pharmacy and then constructed a plan in order to change these. 
The intervention led to an increase in structured work with regard to patient education in 
participating pharmacies. 
 
In SA, nurses or other heath professionals may handle medicines dispensing provided it is 
under the responsibility of a pharmacist. The patients interviewed in the present study 
may have had their medicines dispensed by both the pharmacist and another pharmacy 
staff member. This study was structured to determine difference in counseling 
performance by various other dispensing health care providers versus pharmacists.    
 
Mode of interaction Pharmacist-Patient:  
Studies assessing counseling performance have revealed that counseling is usually based 
on a monologue model, meaning that the pharmacist gives information to the patients 
without actively engaging them in the process; the level of information is usually brief, 
basic and non-individualized (Rutter et al. 2004). This study will assess the extent to 
which SA pharmacists engage dialogue with their patients by asking them questions and 
measuring their satisfaction with verbal counseling provided. 
 
Studies in South Africa: 
In South African literature, observations of some researchers on patient’s knowledge and 
attitudes are noteworthy.  
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Dowse and Ehlers (2001) pointed out that an inability to read and understand written 
medication instructions may be a major contributory factor to non-compliance in certain 
patient populations, particularly in countries with a high illiteracy rate such as South 
Africa. The researchers studied later (Dowse and Ehlers 2005) the influence of medicine 
labels incorporating pictograms on the understanding of instructions and on adherence. A 
high adherence of greater than 90% was found for 54% of the experimental group, 
compared with only 2% of the control group. The presence of pictograms was found to 
contribute positively to both understanding of instructions and adherence.  
 
Myburgh et al (2005) set out a study to assess the influence of race and socio-economic 
status (SES) on perceived quality of care from health care providers. Both race and SES 
were significant predictors of levels of satisfaction with the services of the health care 
provider, after adjusting for gender, age, and type of facility visited. White and high SES 
respondents were about 1.5 times more likely to report excellent service compared to 
Black and low SES respondents, respectively. They concluded that in South Africa, race 
and SES are not synonymous and can no longer be considered reliable proxy indicators of 
one another. Each has distinct and significant but different degrees of association with 
patient satisfaction.  
 
Even though this study is not designed to highlight the impact of SES or race on the 
counseling practice on itself, these two elements may be associated with the patients’ 
perceptions about their relation with the pharmacists. The patient assessment outcomes 
will partially give answer to this issue. 
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3 RESEARCH DESIGN AND METHODOLOGY 
 
 
3.1 STUDY DESIGN 
 
This study was designed as an observational cross-sectional survey, conducted over a 
nine-month period, between January 2006 and September 2006. This design provided a 
“snapshot” of the counseling services offered in community pharmacies in a section of 
Gauteng at a point in time. Interviews with both patients and pharmacists were 
completed. 
 
Ethics clearance was successfully applied for protocol number M051031. Patients and 
pharmacists alike provided written informed consent that was completely voluntary 
(Appendix-1 and -2). 
 
Questionnaires were kept anonymous. To protect pharmacist confidentiality, the names of 
any pharmacist or pharmacy were not recorded.  However, a description of pharmacy 
type and location, approximate age of the dispensing pharmacist and the level of activity 
in the pharmacy were noted. Pharmacy staff was divided into two-age scales, young (less 
than 35 years old) and old (35 or more years old) to accommodate the differences in 
pharmacy curriculum. Level of activity was estimated as not busy = less than 3 patients 
waiting at the desk, busy = 3 to 7 patients waiting, very busy= more than 7 patients in the 
queue. 
 
3.2 SELECTION OF SURVEY SITES AND PARTICIPANTS 
 
3.2.1 Pharmacies selection 
 
Pharmacies were sampled from the Johannesburg and Pretoria regions. The diversity of 
age, race, gender and patient demographics offered by these two metropolitan areas can 
provide a suitable sample of the SA population (http://en.wikipedia.org/wiki/Gauteng). 
Regional representation may be limited by this sample. Participation has been offered to 
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all community pharmacies randomly selected in Pharmacy info guide South Africa 2003 - 
A comprehensive directory and quick reference to suppliers, medical aids, pharmacies 
and general contacts. (Leslie Bassin 2003). At that time, a tentative to obtain an updated 
list of pharmacies from SAPC failed. 
3.2.2 Patients selection 
 
All patients attending the selected pharmacies were eligible for the study. The including 
criteria were that the patients must give an informed consent to enter the study. The 
excluding criteria were that patients must not be in hurry.  
 
3.3 CONSTRUCTION AND IMPLEMENTATION OF THE SURVEY 
 
The study was conducted in two phases:  
Phase-I: Pharmacist-Self-Assessment (PSA);  
Phase-II: Patient- Interview Assessment (PIA). 
3.3.1 Selection process 
 
Participation by pharmacists was voluntary upon request. Participating pharmacists were 
required to complete the self-assessment questionnaire concurrently. Permission was 
sought from the pharmacist for the researcher to access the patient base for interviews. 
The pharmacists who agreed with these criteria were selected. 
For patients, the selection process was as follows: 
a) Pharmacists were contacted and asked to allow interviews of their patients; 
b) A pharmacist who agreed was selected; 
c) The day of the investigational visit was not communicated to the pharmacist; 
d) On the investigational day, the interviewer showed up, randomly selected patients 
during the day and asked them to participate in the study; 
e) Patients, who agreed, signed an informed consent form before giving any 
information; 
f) Each participating patient was helped to complete the questionnaire by the       
interviewer. 
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The final sample included 60 pharmacies (19 pharmacies from Pretoria region and 41 
pharmacies from Johannesburg region) and 179 patients (62 subjects from Pretoria region 
and 117 subjects from Johannesburg region). The study sample characteristics are 
detailed in the results. 
3.3.2 Designing the questionnaire instruments 
 
In the literature, different methods are used to evaluate the counseling practice in 
community pharmacies. These methods are basically focused on mystery shoppers and 
interview techniques using standardized outcomes measures. The validated published 
instruments (Azzopardi 2000) inspired the format of the present investigational 
questionnaires. Some items were drawn from the “Confidential Inspection Questionnaire 
to establish the nature, extent and standard of pharmaceutical services in community 
pharmacies” (www.pharmacouncil.co.za/documents2004). This SAPC questionnaire 
includes among others the following items: 
- The pharmacy has copies of electronic access to: the latest edition of MIMS, the 
latest edition of either the MDR or SAMF, a copy of Pharmacy Act,1974 … 
- Dispensed medicine is labelled as required in Regulation 8(4) of Act 101 of 1965; 
- The pharmacist obtains all the relevant patient information before dispensing the 
prescription; 
- The pharmacist gives advice to the patient or care-giver after the prescription has 
been dispensed; 
- Support aids are used when supplying advice (pamphlets information leaflets, 
manufactures reclaim inserts, computer printouts, visual adds e.g. diagrams); 
- How many pharmacists-interns are undergoing practical training in the pharmacy? 
- How many registered pharmacists assistants (post-basic) work in the pharmacy? 
- Who hands the medicines to the patient or caregiver? 
- Generic substitution is applied in accordance with Section 22(F) of Act 101 of 
1965. 
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3.3.2.1 Pharmacist Self-Assessment Instrument 
 
The questionnaires were designed to be self-completed. One form must be completed for 
every pharmacy. The Pharmacy Superintendent or Proprietor Pharmacist was empowered 
for the accurate completion of the questionnaire. The questionnaires were structured in 
such way to allow getting outcomes based on the study objectives. They included a 
section for the identity of the pharmacy and four sections containing closed-questions 
related to: 
- Measurement of the current nature and extent of counseling; 
- The actual feasibility of counseling in daily routine; 
- The communication barriers;  
- The knowledge of pharmacists about GPP Gold standard.  
There was a further open-section at the end for any additional information or comments. 
 
The main outcome measures of the actual counseling consisted of a set of twenty items 
related to drug information and to counseling process steps (pharmacist behaviour). Drug 
information items as well as pharmacist’s behavioural points were documented to assess 
whether any or all of the mentioned events actually occurred. With reference to the latest 
five patients, every pharmacist was asked to tell in how many cases he/she did actually 
accomplish each of the events mentioned. A score of zero meant the event did not 
happen; a score of five meant the pharmacist totally accomplished the event in all his/her 
five latest patients. 
 
Assessing the nature of counseling in the current environment of community pharmacies 
encompassed the format of counseling and the type of information often given. Assessing 
the extent of counseling implicated measuring the frequency with which pharmacists 
provide any verbal or written advice, the frequency with which each specific advice is 
carried out and the frequency with which pharmacists achieved the counseling process 
steps on a one-to-one basis. 
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The evaluation of factors that may influence counseling was achieved by rating the 
importance of communication barriers related to pharmacist and patient; identifying the 
outcomes controlled by the pharmacy characteristics and dispenser’s demographics; 
verifying the availability of SA GPP guidelines in the pharmacy and rating the difficulty 
to accomplish specific requirements in dealing with impaired persons. 
 
The acceptability and feasibility of self-assessment by the community pharmacists in 
their daily routine was based upon the meaningfulness of the results obtained. 
Respondents’ suggestions, remarks and comments were expected to describe attitudes 
towards counseling practice and find out pragmatic guidelines for community pharmacies 
in SA. 
 
3.3.2.2 Patient Interview Assessment Instrument 
 
 
The interview was aimed at identifying how well and to what extent patients value the 
performance of pharmacist’s counseling and determining whether their needs are met. It 
was crucial that the patient interview be strategically developed and conscientiously 
conducted. To seek detailed responses, the questionnaire included both closed and open-
ended questions. The questionnaire was strictly restricted to collecting information 
received and the patient’s perception of the pharmacist’s role in counseling to ensure that 
constraints of the ethical issues were abided by. The same twenty items were also 
administered to the patients in order to check whether the events were achieved by the 
dispenser. In order to calculate the percentage of patients where the process was 
completely, partially or not at all achieved, each item was coded 1 or 0 when it had been 
or not achieved. 
 
3.3.3 Validation process 
 
The first drafts of the questionnaires were sent by mail to a small pilot group of 25 
pharmacists in order to provide an estimate of the time needed for responding and the 
validity of random variables chosen as outcomes measures. Eleven questionnaires were 
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sent back within two weeks but only seven were valid. The feedback allowed removing 
the perceived ambiguities in each question. Then, the validated questionnaires were ready 
for investigation and the mailing technique was abandoned in favour of direct visits. 
 
Investigational visits took place in pharmacies with the permission from the respective 
responsible persons or managers. Pharmacists were assessed on their daily practice of 
counseling and on supplementary needs to successfully accomplish their counseling task. 
Pharmacist responses could only be validated against the patients’ responses in the 
respective pharmacies. Data were analyzed quantitatively and qualitatively. 
 
Quantitative analysis 
 
For each study phase, the results from individuals were calculated. Categorical variables 
were graded to allow quantitative analysis. Outcomes measures scores were constructed 
to quantify the extent to which any event occurred. The prevalence of counseling and 
rates to which the events tested occurred were expressed as percentage. Descriptive 
statistics such as frequency, mean, and cross-tabulation were calculated using SPSS 11.5 
software package (SPSS Inc.2006) to summarize the final data. Chi-square and ANOVA 
tests had been considered to examine the relationships between predictors and outcome 
measures (Petrie and Sabin 2005). A probability of 5% or less (p≤0.05) was considered 
significant. Frequency distribution and relative percentage distribution are presented in 
tables and charts using Microsoft Excel 2003. 
 
Qualitative analysis 
 
The qualitative outcomes were based on the open-ended questions administered to both 
the pharmacists and the patients. Respondents’ comments, remarks and suggestions 
recorded were interpreted using constant comparative analysis technique. From this 
technique, opinions from pharmacists and patients were challenged. 
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4 PHASE-I STUDY QUANTITATIVE RESULTS 
 
   
4.1 ACCEPTABILITY AND FEASIBILITY OF SELF ASSESSMENT  
 
 
Table-1 shows that among 83 pharmacies randomly selected, fifteen pharmacists 
contacted did not agree to participate. Considering the 83 cases as 100%, the refusal rate 
accounts for about 19.3% and this gave the rate of acceptability of about 80.7%. Of 67 
questionnaires distributed, 60 were given back completed on time and this gave 72.3% as 
the rate of feasibility. 
 
Table 1 Percentage of pharmacists who did self-assessment in daily routine  
 
 Johannesburg Pretoria  Total % 
Pharmacists contacted  55 28 83 100.0 
Refusal to participate 9 7 15  
Acceptability  46 21 67 80.7 
No feedback  5 2 9  
Feasibility  41 19 60 72.3 
 
 
4.2 STUDY SAMPLE CHARACTERISTICS 
 
Table 2 shows the final sample analysed including 41 pharmacists (68.3%) from 
Johannesburg region and 19 pharmacists (31.7%) from Pretoria region.   
 
Four types of pharmacy-settings were identified, 34 independent owned pharmacies, 11 
chain-pharmacies, 8 clinic settings and 7 linked-pharmacies giving a magnitude of 56.7 
%, 18.3 %, 13.3 % and 11.67 % respectively. This categorization was made according to 
Pharmacy Info Guide South Africa - A comprehensive directory and quick reference to 
suppliers, medical aids, pharmacies and general contacts (Leslie Bassin 2003). 
Independent pharmacy is a family business; chain-pharmacies operate inside 
supermarkets and are large group businesses; clinic-pharmacies are connected to private 
clinics; linked-pharmacies are small group owned pharmacies.  
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Concerning the level of activities, 6 (10%) pharmacies had less than 3 patients in the 
queue; 49 (81.7%) pharmacies had between 3 and 7 patients in the queue whilst 5 (8.7%) 
pharmacies had more than 7 patients queuing. The question may arise of how many 
pharmacists are needed on duty. 
 
 
Table 2 Frequency distribution of pharmacies characteristics 
 
 Location Frequency Percent 
 Johannesburg 41 68.3 
  Pretoria 19 31.7 
  Total 60 100.0 
Type   
 Clinic 8 13.3 
  Independent 34 56.7 
  Chain 11 18.3 
  Linked 7 11.7 
  Total 60 100.0 
Workload level   
 Not busy 6 10.0 
  Busy 49 81.7 
  Very busy 5 8.3 
  Total 60 100.0 
 
 
Table 3 indicates that the random selection included 31 young pharmacists (<35 years) 
and 29 older pharmacists (35 years or more). Among them, 38 were males (63.3%) and 
22 females (36.7%). The gender odd ratio tended to be 1.7 in favour of males in this 
random selection. This situation may be due to willingness from males to participate or to 
the fact that only one pharmacist per pharmacy was allowed to participate even though 
there were many.  
 
Apart from the pharmacists themselves, there were 22 (36.7%) pharmacist-assistants, 6 
(10%) pharmacist-interns and 4 (6.7%) other staff members identified as dispensers of 
medicines in the selected pharmacies. 
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Table 3 Frequency distribution of dispensers by age, gender and qualification (N=60) 
 
 Frequency (N=60) Percentage 
Pharmacist’s  age   
Young (< 35 years old)  31 51.7 
Old (>35 years old) 29 48.3 
Pharmacist’s  gender   
Male 38 63.3 
Female 22 36.7 
Dispenser’s categories   
Pharmacist Assistants (basic and post-basic) 22 36.7 
Pharmacist Interns 6 10.0 
Other staff members 4 6.7 
 
 
Legally, the SA Medicines Regulatory Authority (SAPC 1997) authorises all three 
categories - pharmacist assistant, pharmacist intern and other agreed health personnel- to 
dispense medicines under the supervision of the pharmacist responsible. The 
accountability of everyone is defined with regard to what should be done and who should 
dispense what medicine. This study was not designed to identify task-attribution; it was 
assumed that the pharmacists are aware of the SAPC standards.  Nevertheless, among the 
suggestions made by pharmacists to improve the counseling process, a need for more 
pharmacists and less pharmacist assistants raised. 
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4.3 NATURE AND EXTENT OF COUNSELING PRACTICE 
 
4.3.1 How often pharmacists would counsel patients in daily routine? 
 
Table 4 shows about 95% of pharmacists said they would do counseling spontaneously 
each time they dispense any drug. About 11.7% of pharmacists would do it only when if 
the patient seeks information and 6.7% only for prescribed drugs.  
 
Table 4 Frequency with which pharmacists expect to counsel patients 
 
 
How often do you give counseling to your patient? 
 
N(60) 
 
% 
Spontaneously each time I dispense any drug 57 95.0 
Only for prescribed drugs 4 6.7 
When if the patient seeks information 7 11.7 
 
4.3.2 When do pharmacists give supplementary written advice? 
 
Table 5 indicates that, when pharmacists were questioned about how often they give 
supplementary written information, only 13.6% said doing it always while 55.9% 
contended doing it some of the time and not always. About 23.7% prefer doing it only if 
the patient asks for it; 6.8% of pharmacists would do it only if the leaflet is not provided 
with the container. 
 
Table 5 Frequency with which pharmacists give supplementary written information 
  
How often do you give supplementary written 
information? 
Frequency Percent Valid 
Percent 
Always 8 13.3 13.6 
Some of the time 33 55.0 55.9 
If the leaflet is not provided  4 6.7 6.8 
If the patient asks for it 14 23.3 23.7 
Total 59 98.3 100.0 
Missing System 1 1.7  
Total 60 100.0  
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4.3.3 How do pharmacists assess patients’ understanding and satisfaction?  
 
As shown in Table 6, when the pharmacists want to assess the understanding of advice 
given to their patients, 70% ask them if they understood what was said; 33.3% question 
patients, but only 26.7% ask patients to relate the information back to them. 
  
 
Table 6 Assessment of patient understanding and satisfaction with verbal advice 
 
 N(60) % 
How do you assess patient understanding of the advice?                 
I question them 20 33.3 
I ask them if they understood my counseling 42 70.0 
I ask them to relate the information back to me 16 26.7 
How do you assess patients' satisfaction?                                          
I ask them 34 56.7 
I run surveys 1 1.7 
I have a feedback box in the pharmacy 5 8.3 
None of the above 20 33.3 
 
To assess patients’ satisfaction with their verbal counseling, about 56.7% of pharmacists 
would just ask the patients about their satisfaction; 8.3% have a feedback box in the 
pharmacy and only one pharmacist said he might run surveys. About 33.3% of 
pharmacists likely do not assess the satisfaction of their patients in their daily routine or 
would do it by other means. 
  
4.3.4 Type and extent of information related to use of the medication 
 
Table 7 summarises the type and extent of drug information the pharmacists used to give 
their patients. It appears that the focus was on how to take medicines (96.7%) whilst little 
was accorded to what to do with the unused medicine at the end of the treatment (50%) 
and worst on what to do if the medicine is lost or spoiled (13.3%). Care should be taken 
that the duration of validity is limited for all medicines and that is worth being related to 
the patient as often as possible, if not always. 
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Table 7 Type and extent of information related to use of medications 
 
 
Information about the use of medications 
Pharmacists 
N % 
1. How to take the medication 58 96.7 
2. How long should the medication be taken 54 90.0 
3. How should the medication be stored 50 83.3 
4. Why the medication should be taken in whole course 49 81.7 
5. Anticipated adverse reactions associated with the medicines 47 78.3 
6. What is the therapeutic objective of the medication 47 78.3 
7. Contra-indications of medication 42 70.0 
8. What is the maximal dose 36 60.0 
9. What can happen if the medication is not properly or not used at all 35 58.3 
10. When not to take the medication 32 53.3 
11. What to do with the unused medicine at the end of the treatment 30 50.0 
12. How long before the medication takes effect 32 53.3 
13. What to do if the medicine is lost or spoiled 8 13.3 
 
4.3.5 Type and extent of information related to side effects  
 
Table 8 shows that when the advice is about side effects, the pharmacists will often focus 
on the kind of side effects which may occur (91.7%) and less often on the seriousness 
(51.7%) or duration of the side effects (21.7%). About 55% of pharmacists would 
routinely advise patients in what case to consult the doctor or the pharmacist before a 
next appointment. 
 
Table 8 Type and extent of information related to side effects of medications 
 
Information about the side effects 
 
Pharmacists 
N % 
1. What kind of side effects may occur 55 91.7 
2. What intervention can patients take to alleviate side effects 36 60.0 
3. What is the level of seriousness of a side effect 31 51.7 
4. What symptoms will disappear and what symptoms will persist 21 35.0 
5. How to recognize side effects 19 31.7 
6. For how long side effects persist 13 21.7 
7. In what case to consult the doctor or the pharmacist before a next appointment 33 55.0 
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4.3.6 Actual achievement rate of drug informational items 
 
The extent to which counseling items were actually achieved was based on scores 
realized by pharmacists in their last five patients (0-5). When all five patients were given 
an item, this item was totally achieved. When all items were achieved in a patient, the 
process was completely achieved. 
 
Table 9 shows that information about directions for use was given to 97.2% of patients. 
At the other extreme, advice on missing a dose was given to only 23% of patients. Other 
items were covered in the range between 31.4% and 88.6%. On average about 58.4% of 
patients were counseled on at least one item.  
 
Table 9 Frequency of patients who received advice on drug information items  
 
Percentage of patients actually counseled among the 5 last received by each pharmacist.  
N=valid number of pharmacists per item; Nx5=maximum number of patients expected; 
Nobs=number of patients actually counseled per item.  
  
DRUG INFORMATION ITEMS N Nx5 Nobs % 
1.Directions for use 58 290 282 97.2 
2.Dosage regimen and duration of consumption 58 290 257 88.6 
3.Name, class and purpose of the medication 57 285 236 82.8 
4.Storage recommendations 58 290 174 60.0 
5.Side effect profile (management and prevention) 57 285 154 54.0 
6.Precautions to be aware of 57 285 152 53.4 
7. Drug interactions with other drugs, with food, etc 57 285 144 50.6 
8.When does the medication begin to work and benefits 56 280 114 40.8 
9.Non pharmacological intervention 56 280 85 31.4 
10.Advise on missing a dose 55 275 63 23.0 
Total  
 2845 1661 58.4 
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4.3.7 Actual achievement rate of counseling behavioural items 
 
As shown in Table 10, almost 98.9% of dispensers greeted patients and 96.2% thoroughly 
reviewed the medication script. However, only 28.9% asked patients their consent for 
counseling. About 75.4% of dispensers offered generics for substitution. On average, at 
least one behavioural item was achieved in 67% of patients. 
 
Table 10 Frequency distribution of patients to whom behavioural items were achieved 
 
Percentage of patients actually counseled among the 5 last received by each pharmacist.  
N=valid number of pharmacists per item; Nx5=maximum number of patients expected; 
Nobs=number of patients actually counseled per item. 
  
PHARMACIST BEHAVIOURAL ITEMS N Nx5 Nobs % 
1.Dispenser reviewed the script thoroughly 58 290 287 98.9 
2.Dispenser greeted patient and established comfort level 54 270 279 96.2 
3.Dispenser did actual counseling on the medication offered 57 285 248 88.6 
4.Dispenser introduced generics for substitution 54 270 215 75.4 
5.Clarification of any uncertainties/ 55 275 189 68.8 
6.Warning about consuming other drugs simultaneously  57 285 166 58.2 
7.Patient invited back 56 280 155 55.4 
8.Dispenser tried to obtain initial drug related information 54 270 131 48.5 
9.Counseling points summarized 55 275 122 44.4 
10.Dispenser asked patient a consent for counseling  58 290 78 28.9 
Mean  
 2790 1870 67.0 
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4.4 IDENTIFICATION OF FACTORS INFLUENCING COUNSELING  
 
 
A set of factors have been tested in order to weigh their impact on the quality and the 
extent of counseling. The deterministic factors were clustered as: Barriers in 
communicating with patients, Pharmacist’s knowledge of Gold Standard, Pharmacist’s 
demographics, Pharmacy characteristics and Patient’s behaviour. 
 
4.4.1 Impact of counseling barriers 
 
Each pharmacist on a 5-point grade-scale (1=0%, 2=25%, 3=50%, 4=75%, and 5=100%) 
appreciated the impact of counseling barriers related to pharmacists and patients.  
In order to simplify the interpretation, the impact was graded by the mean percentage as 
shown in Table-11 below. A grade equal or above 50% means the outcome measure has 
important negative impact on counseling.  
 
The important counseling barriers were: patients request not to be counseled because they 
already know about the medication (51.4%) and pharmacist lack of time (50%).   
 
Table 11 Rated barriers on counseling performance  
  
Type of barrier   N Mean 
% 
SD 
Pharmacist-lack of time 56 50.0 27.4 
Pharmacist-lack of staff 52 43.3 23.3 
Pharmacist-distractions such as noise, phone call, etc. 51 43.1 21.8 
Pharmacist-lack of experience with patient counselling 43 32.6 25.9 
Patients are in a hurry 47 47.9 24.9 
Patients request not to be counseled because they already know about 
the medication 
53 51.4 26.6 
Patients have hearing or language problems 52 44.7 26.8 
Patients have elderly related cognitive problems 44 33.0 22.1 
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4.4.2 Knowledge of SA GPP Gold Standard 
 
One of the preoccupations was then to ascertain whether the national Gold Standard of 
counseling embodied in SA GPP is sufficient and well known to the pharmacists and also 
to rate the difficulty of accomplishing the requirements.  
 
Figure-1 shows the number of pharmacists keeping a copy of SA GPP latest edition. To 
the question assessing the availability of a copy of SA GPP, 47 pharmacists affirmed 
keeping a copy in the pharmacy, 10 pharmacists did not have it and 3 did not answer the 
question. The evidence of awareness about GPP guidelines was then 78.3%. 
 
Figure 1 Pharmacists keeping a copy of SA GPP 
47
10
3
Have SA GPP guidelines Do not have it Missing system
 
 
Among the 10 pharmacists who did not keep a copy of SA GPP, four declared they had 
never heard of the SA GPP; three said, “They were not supplied with”, and one declared 
it was not necessary at the time then, did not follow up on recommendations. This finding 
showed there were about 23% of community pharmacists who were not yet aware of the 
existence of SA GPP guidelines. It means the counseling they were applying was not 
inspired or directed by the Gold Standard but by the experience. Nobody can comply 
with an unknown rule. Therefore, the ignorance is a predictor of bad counseling. 
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4.4.3 Difficulty to comply with special SA GPP requirements 
 
It appeared from the assessment that some GPP requirements are easy to comply with 
(rate <50% of difficulty) whilst others are much more difficult to execute (rate >50%).  
As shown in Table 12 below, the mean grade of difficulty is less than 50% for all GPP 
general considerations meaning an easily accomplishment.  
 
Table 12 Mean rates of difficulty to accomplish special SA GPP requirements  
 
 
 
N Mean 
% 
SD 
GPP general considerations in communicating with the patient    
Treating the patient with respect and interest, caring and willingness to help 49 41.3 40.4 
Having adequate and correct knowledge about the subject under discussion 57 42.1 40.7 
Being relaxed and attentive by maintaining eye contact with patient 58 36.6 38.7 
Being sensitive towards the patients need for privacy and confidentiality 59 44.5 38.6 
Asking open-ended questions and listening and observing without 
interrupting 
58 44.4 36.3 
GPP special considerations in communicating with the elderly    
Focusing on their abilities, rather than disabilities 51 50.5 35.5 
Assessing them individually and reassess often 53 52.8 33.9 
If the elderly are unable to give information, using family or caregivers as 
resources 
52 52.4 32.9 
Ensuring that the disabled should have easy access and seating 51 51.0 38.7 
GPP approaches based on special need for the hearing impaired    
Eliminating as much background noise as possible 48 45.8 31.9 
Augmenting oral communication with other methods (writing, pictures, 
signs… 
53 53.3 35.0 
Facing the person directly to achieve eye contact and enable lip reading, 
speak slowly and clearly without shouting, and avoid unnecessary details 
48 50.5 39.4 
Communicating with visually impaired    
For printed communication, use black printing with larger fronts on white 
paper 
45 57.2 33.1 
Taking position what needs attention so it's at the centre of the visual field 48 49.5 38.1 
GPP approaches based on special need for cognitive impairment    
Gaining the patient's attention, and address one topic at time by giving 
simple and relevant information 
45 51.7 39.0 
Upgrading the patient communication facilities (e.g. counseling booths) 43 55.2 38.4 
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In respect to communicating with the elderly, about all requirements are difficult to 
accomplish. In hearing impaired patients, it is easier to eliminate as much background 
noise more possible (45.8%) than augmenting oral communication with other methods 
(writing, pictures, signs…) or facing the person directly to achieve eye contact and 
speaking slowly without shouting (53.3% and 50.2%). In dealing with the vision 
impaired, the provision about using black printing with larger fronts on white paper is not 
so easy to accomplish (57.2%). In dealing with the cognitively impaired, pharmacists 
found it difficult to upgrade the patient communication facilities and gain the patient’s 
attention by addressing one topic at a time. 
 
The meaning of this outcome is that the provisions of counseling in disabled persons 
could never have been completed since pharmacists were currently finding it difficult to 
comply with these GPP provisions. This also may be a factor to keep in mind. 
 
4.4.4 Chi-Square tests summaries   
 
Chi-square tests were used to look at the statistical significance of an association between 
predictors and determining outcomes. With SPSS software, Crosstabs and Chi-square 
tests (Pearson; Likelihood-ratio; Linear-by –Linear association) are used to assess the 
hypothesis that the row and column variables are independent, without indicating strength 
or direction of the relationship. The small size of the sample did not allow making 
rigorous analysis. However some trends are underlined in the following. 
 
Table 13 shows that the number of pharmacists who did actual counseling totally (in five 
latest patients) was related to city, being higher in Pretoria than Johannesburg (41.2% 
versus 13.5%). The less p-value, Pearson Chi-square (p=0.023) or Likelihood-ratio Chi-
square (p=0.027), meant that, under the study conditions, the observed result was less 
likely to occur under the null hypothesis.  
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Table 13 Relationship City and Dispenser did actual counseling on the medication 
  
Crosstab No or Partially Totally  
Level of achievement < 5 patients 5 patients Total 
City Johannesburg Count 32 5 37 
  % within city 86.5 13.5 100 
 Pretoria Count 10 7 17 
  % within city 58.8 41.2 100 
Total  Count 42 12 54 
  % within city 77.8 22.2 100 
 Chi-Square Tests Value Df Asymp. Sig.  
(2-sided) 
Pearson Chi-Square 5.157166 1 0.023150 
Likelihood Ratio 4.867011 1 0.027374 
Linear-by-Linear Association 5.061663 1 0.024460 
N of Valid Cases 54   
 
 
As shown in table 14, even though the difference is not statistically significant (Pearson 
Chi-square, p≥0.062; Likelihood-ratio p≥0.055), female pharmacists performed better 
than males about advising dosage regimen and duration of consumption (80.9% versus 
56.8%).  
 
Table 14 Relationship Gender and Dosage regimen and duration of consumption  
 
Crosstab  No or Partially Totally  
Level of achievement < 5 patients 5 patients Total 
Gender Male Count 16 21 37 
  % within gender 43.2 56.8 100 
 Female Count 4 17 21 
  % within gender 19.1 80.9 100 
Total  Count 20 38 58 
  % within gender 34.5 65.5 100 
Chi-Square Tests Value Df Asymp.Sig.(2-sided) 
Pearson Chi-Square 3.471435 1 0.062437 
Likelihood Ratio 3.660072 1 0.055731 
Linear-by-Linear 
Association 
3.411583 1 0.064740 
N of Valid Cases 58   
 
However, Table 15 shows that male pharmacists performed better than females about 
obtaining initial drug related information (30.3% versus 9.5%), even though again the 
difference is not statistically significant (Pearson Chi-square, p≥0.073; Likelihood-ratio 
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p≥0.060). So, gender is really not a determining predictor to consider in this assessment 
technique. 
 
Table 15 Relationship Gender and obtaining initial drug related information 
 
Dispenser tried to obtain initial drug related information No or Partially Totally  
Level of achievement < 5 patients 5 patients Total 
Gender Male Count 23 10 33 
  % within gender 69.70 30.30 100 
 Female Count 19 2 21 
  % within gender 90.48 9.52 100 
Total  Count 42 12 54 
  % within gender 77.78 22.22 100 
Chi-Square Tests Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 3.205937 1 0.073371 
Likelihood Ratio 3.514534 1 0.060832 
Linear-by-Linear Association 3.146568 1 0.076086 
N of Valid Cases 54   
 
 
Surprisingly, Table 16 shows that the impact of workload was the contrary to what would 
be expected. Pharmacists in very busy pharmacies realized a greater achievement in 
summarizing counseling points than those in busy or not busy pharmacies (Likelihood-
ratio Chi-square p=0.003). This result is not meaningfulness since there were more than 6 
cells with an expected count less than 5, but is just indicative of poor correlation between 
workload and extent of counseling in the selected pharmacies. 
 
Table 16 Relationship Workload and Counseling points summarized 
 
Level of achievement < Five patients Five patients Total 
Likelihood-ratio Chi-square p=0.003 N % N % N 
Workload Not busy 6 100.0 0 0 6 
 Busy 37 84.1 7 15.9 44 
 Very busy 1 20.0 4 80.0 5 
Total  44 80.0 11 20.0 55 
6 cells (66.6%) have expected count less than 5. 
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5 PHASE-II STUDY QUANTITATIVE RESULTS 
 
 
5.1 STUDY SAMPLE CHARACTERISTICS 
 
As reported in Table 17, the final study sample included 117 patients (65.4%) from 
Johannesburg region and 62 patients (34.6%) from Pretoria region. The ratio of about ½ 
was respected as for the PSA. Approximately 60.3% of patients were with younger 
pharmacists and 39.6% with older pharmacists; 59.2% of patients were associated with 
pharmacies supervised by male pharmacists and 40.8% by female pharmacists.  
 
Table 17 Frequency distribution of patients by city, age and gender 
 
  Frequency(N=179) Percent 
City Johannesburg 117 65.4 
 Pretoria 62 34.6 
Age Younger 108 60.3 
 Older 71 39.7 
Gender Male 106 59.2 
 Female 73 40.8 
 
Table 18 shows that 67 (40.9%) patients interviewed were connected with independent 
pharmacies, 40 (24.4%) with chain, 34 (20.7%) with clinic and 23 (14.0%) with linked 
pharmacies. About 63.1% of patients interviewed came from busy pharmacies, 25.1% 
from not busy and 11.7% from very busy pharmacies.  
 
Table 18 Frequency distribution of patients by Pharmacy type and Workload 
 
   Frequency(N=179) Percent Valid Percent 
Pharmacy type Clinic 34 19.0 20.7 
 Independent 67 37.4 40.9 
 Chain 40 22.3 24.4 
 Linked 23 12.8 14.0 
 Total 164 91.6 100.0 
 Missing System 15 8.4  
Workload  Not busy 45 25.1 25.1 
 Busy 113 63.1 63.1 
 Very busy 21 11.7 11.7 
 Total 179 100.0 100.0 
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As shown in Table 19, about 53.4% of patients had their medicines dispensed by the 
pharmacist alone whilst either the pharmacist assistant (15.7%) or other staff member 
(7.3%) served the remaining. Some patients checked a combination of dispensers where 
the pharmacist was usually present.  Those who could not identify the dispenser 
represented 7.3%. This means some dispensers did not introduce themselves to the 
patient, and at the best, there was no distinctive sign to recognize the pharmacist amongst 
staff members.  
 
Table 19 Frequency distribution of patients by category of dispensers 
 
Who dispensed the medication? Frequency(N=179) Percent Valid Percent 
 Pharmacist [1] 95 53.1 53.4 
 Assistant [2] 28 15.6 15.7 
 Other staff member [4] 13 7.3 7.3 
 I don't know [5] 13 7.3 7.3 
 1&2 18 10.1 10.1 
 1&4 8 4.5 4.5 
 2&4 1 0.6 0.6 
 1&2&4 2 1.1 1.1 
 Total 178 99.4 100.0 
Missing System 1 0.6  
 
With regard to the customary habits of patients, Table 20 shows that 94 (52.8%) patients 
usually attend the same pharmacy where they purchase medicines; 21.4% attend 
frequently and 20.8% rarely, whilst for 5.1% it was the first visit.  
 
Table 20 Frequency distribution of patients by customary habits  
  
How often do you get your medicines in this 
pharmacy? 
Frequency Percent Valid 
Percent 
Always 94 52.5 52.8 
Frequently 38 21.2 21.3 
Rarely 37 20.7 20.8 
First time 9 5.0 5.1 
Total 178 994 100.0 
Missing System 1 0.6  
Total 179 100.0  
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5.2 NATURE AND EXTENT OF PATIENT COUNSELING PRACTICES 
 
5.2.1 Prevalence of counseling achieved to the patients interviewed 
 
Table 21 indicates that, to the question addressed to patients if the people who dispensed 
their medicines during the investigation day gave them any medication-advice, 74.2% of 
patients declared “Yes” and 25.8% “No”.  
 
Table 21 Percentage of patients given any verbal advice 
 
Did the person who dispensed your medicine 
give you any oral advice? 
Frequency Percent Valid 
Percent 
Yes 132 73.7 74.2 
No 46 25.7 25.8 
Total 178 99.4 100.0 
Missing System 1 0.6  
Total 179 100.0  
 
5.2.2 Method in which counseling was given to patients 
 
As shown in Table 22, the outcome found through measurement of patient encounters 
indicates that 6.6% of patients received drug information as only a printed label on the 
packet and 2.2% as only insert leaflet. About 46.7% of patients received only verbal 
advice; both written and verbal information occurred to 44.5% of respondents.  
 
Table 22 The format in which patients received counseling 
 
 Frequency Percent Valid Percent 
Label on packet 9 5.0 6.6 
Leaflet 3 1.7 2.2 
Verbal 64 35.8 46.7 
Both verbal and written 61 34.1 44.5 
Total 137 76.5 100.0 
Missing System 42 23.5  
Total 179 100.0  
 
The combination of this data indicates that, when counseling was given, about 91.2% of 
pharmacists gave oral advice supported by a supplementary written advice in 53.3% of 
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patients where necessary. This supports the evaluation made by pharmacists saying they 
often give supplementary written information some of the time in about 55.9% of cases. 
5.2.3 Patient’s satisfaction with the verbal counseling received 
 
Table 23 shows that about 78.4% of patients were very satisfied with the verbal 
counseling provided whilst a small number had not been satisfied with the counseling 
given. The concern is that Pharmacists should be keener in providing verbal counseling. 
 
Table 23 Frequency distribution of patients’ satisfaction with verbal advice 
  
How well were you satisfied with the verbal 
counseling received? 
Frequency Percent Valid 
Percent 
Satisfied 109 60.9 78.4 
Fairly satisfied 18 10.1 12.9 
Neither satisfied nor dissatisfied  7 3.9 5.0 
Not very satisfied 4 2.2 2.9 
Not satisfied 1 0.6 0.7 
Total 139 77.7 100.0 
Missing System 40 22.3  
Total 179 100.0  
 
5.2.4 Extent to which investigational items were completed   
 
Table 24 indicates that around 14% of patients may have completely received all ten-drug 
information items. In most of the cases, patients received one to nine items. 
 
Table 24 Frequency distribution of the number of drug items actually achieved 
   
Score on 10 drug information items Frequency(N=179)  Percent 
0 9 5.0 
1 8 4.5 
 2 8 4.5 
 3 12 6.7 
 4 18 10.1 
 5 17 9.5 
 6 20 11.2 
 7 18 10.1 
 8 22 12.3 
 9 22 12.3 
 10 25 14.0 
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As above, Table 25 indicates that the entire behavioural checklist was totally completed 
in about 15.1% of patients and not at all in 2.8% of patients. 
 
Table 25 Frequency distribution of the number of behavioural items completed  
  
Score on 10 behavioural items  Frequency(N=179)  Percent 
0 5 2.8 
 1 11 6.1 
 2 20 11.2 
 3 13 7.3 
 4 20 11.2 
 5 16 8.9 
 6 13 7.3 
 7 9 5.0 
 8 19 10.6 
9 26 14.5 
 10 27 15.1 
 
 
 
Table 26 indicates that on average 6.1 ± 2.9 events occurred out of ten-drug information 
items and 5.8 ± 3.1 steps were completed during each counseling session no matter 
which. 
 
Table 26 Mean number of items achieved during a counseling process 
 
Items Johannesburg         Pretoria           Total 
 
Mean 
value 
(SD) Mean 
value 
(SD) Mean 
value 
(SD) 
Drug information items /10 6.2 (3.1) 5.8 (2.5) 6.1 (2.9) 
Behavioural items /10 6.2 (3.3) 5.2 (2.7) 5.8 (3.1) 
 Total items /20 12.4 (5.9) 10.9 (4.8) 11.9 (5.6) 
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5.2.5 Extent to which investigational items were individually achieved 
 
As it appears from Table 27, about 84.7% of patients received an advice about directions 
for use whilst 46.4% of patients received advice on non-pharmacological information. On 
average, 62.2± 15.2% of patients received 6.1±2.9 items related to drug information. 
 
Table 27 Extent to which drug information items are completed 
 
DRUG INFORMATION ITEMS % Yes % No 
1.Directions for use 84.7 15.3 
2.Dosage regimen and duration of consumption 82.9 17.1 
3.Name, class and purpose of the medication 79.8 20.2 
4.Precautions to be aware of 66.3 33.7 
5.Drug interactions with other drugs, with food, … 60.7 39.3 
6.Side effect profile (management and prevention) 55.8 44.2 
7.Storage recommendations 52.3 47.7 
8.When does the medication begin to work and benefits 46.9 53.1 
9.Advise on missing a dose 46.9 53.1 
10.Non pharmacological intervention 46.4 53.6 
Mean  62.2+15.2  
 
Table 28 shows that about 89.9% of dispensers greeted their patients and 86.9% 
thoroughly reviewed the medication script compared with 47.4% of patients asked 
consent for counseling. On average, 62.1±15.3% of patients benefited 5.8±3.1 
behavioural items. 
 
Table 28 Extent to which counseling steps items are completed 
 
PHARMACIST BEHAVIOURAL ITEMS % Yes % No 
1.Dispenser greeted patient and established comfort level 89.9 10.1 
2.Dispenser reviewed the script thoroughly 86.9 13.1 
3.Warning about consuming other drugs simultaneously  64.1 35.9 
4.Dispenser did actual counseling on the medication offered 63.3 36.7 
5.Clarification of any uncertainties/ 61.2 38.8 
6.Dispenser tried to obtain initial drug related information 59.4 40.6 
7.Patient invited back 52.9 47.1 
8.Dispenser introduced generics for substitution 48.0 52.0 
9.Counseling points summarized 47.7 52.3 
10.Dispenser asked patient consent for counseling  47.4 52.6 
Mean  62.1±15.3  
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5.3 TESTS FOR INFLUENCING FACTORS ON COUNSELING PRACTICE 
 
ANOVA and Chi-square tests served to examine the influence of demographics on the 
counseling nature and extent. Tables below describe some of the relationships observed. 
  
5.3.1 Influence of the city location 
 
Table 29 shows that the mean scores worked out for the achievement of drug 
informational items not significantly different between the two cities (ANOVA test: p ≥ 
0.326). Some difference would be accepted for the achievement of pharmacist 
behavioural items (ANOVA p ≤ 0.04).  
 
Table 29 ANOVA Table: Relationship between Scores worked out and City  
 City  
Statistics 
 Drug information items 
achieved/ 10 
Behaviour items 
achieved/10 
Total 
items/20 
Johannesburg Mean 6.2308 6.1966 12.4274 
  N 117 117 117 
  SD 3.1551 3.2832 5.9990 
Pretoria Mean 5.7742 5.1935 10.9677 
  N 62 62 62 
  SD 2.5247 2.6969 4.8212 
Total Mean 6.0726 5.8492 11.9218 
  N 179 179 179 
  SD 2.5287 3.1219 5.6483 
   Sum of 
Squares 
Df Mean 
Square 
F Sig. 
Score drug 
information * 
City 
Between 
Groups 
(Combined) 8.448 1 8.448 0.969 0.326 
  Within Groups 1543.608 177 8.721     
  Total 1552.056 178       
Score 
pharmacist 
behaviour * 
City 
Between 
Groups 
(Combined) 40.771 1 40.771 4.260 0.040 
  Within Groups 1694.156 177 9.572     
  Total 1734.927 178       
Global score * 
City 
Between 
Groups 
(Combined) 86.337 1 86.337 2.732 0.100 
  Within Groups 5592.568 177 31.596     
  Total 5678.905 178       
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The scores worked out were also unrelated to pharmacy type, pharmacy workload, as 
well as pharmacists’ gender (p>0.05). 
 
 
In addition, from Table 30, the chi-square tests showed that the percentage of patients 
actually counseled was not different between the two cities, nor was it with other 
predictors (p ≥ 0.46). 
 
Table 30 Crosstab: City and rate of verbal counseling 
 
 Crosstab   Did the dispenser give 
any advice 
 
    Yes No Total  
City Johannesburg Count 84 32 116 
    % within City 72.4 27.6 100.0 
  Pretoria Count 48 14 62 
    % within City 77.4 22.6 100.0 
Total Count 132 46 178 
  % within City 74.2 25.8 100.0 
Chi-square Tests Value Df Asymp. Sig. 
(2-sided) 
 
Pearson Chi-Square 0.528(b) 1 0.467   
Likelihood Ratio 0.536 1 0.464   
Linear-by-Linear 
Association 
0.525 1 0.469  
N of Valid Cases 178       
 
 
 
It appeared however that the rates of counseling achievement on some individual items 
were significantly higher in Johannesburg compared to Pretoria.  
 
As shown in Table 31 for example, a significant difference emerged for giving non-
pharmacological intervention (58.3% for Johannesburg versus 25% for Pretoria; p=0.00); 
about 92.9% of Johannesburg patients were very satisfied with the verbal advice received 
compared to 55.6% of patients from Pretoria region (p=0.00). 
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Table 31 Testing impact of City on counseling outcome measures 
 
Outcome measures affected                                                                  Cities       
 
Johannesburg 
% 
Pretoria 
% 
Total 
% 
 
P 
Non-pharmacological intervention 58.3 25.0 46.4 0.00 
Dispenser reviewed the script thoroughly 94.1 74.6 86.9 0.00 
Dispenser tried to obtain initial drug related information 65.7 46.7 58.8 0.02 
Dispenser asked patient a consent for counseling 52.7 36.1 46.8 0.04 
Dispenser introduced generics for substitution 54.5 35.6 48.0 0.02 
Clarification of any uncertainties 67.0 50.9 61.2 0.04 
Counseling points summarized 53.6 36.7 47.7 0.03 
Verbal counseling achieved  54.8 33.9 46.7 0.02 
Patients  Satisfaction level / very satisfied 92.9 55.6 78.4 0.00 
 
More likely, this difference would have a link with patients’ perceptions instead of 
pharmacists’ performance. In essence, pharmacists in clinic settings behaved near exactly 
as their colleagues in private owned or in chain pharmacies did. After all, as the 
education and guidelines stand common to all pharmacists, a difference between them 
would be unjustified after adjusting for age and dispenser’s category. The conclusion 
drawn by Myburgh et al (2005) about the impact of SES and race on patient’s perceptions 
is invaluable but the present study did not test this element. Nevertheless, one should note 
that most of patients in Pretoria region came from Mamelodi and Sunnyside, an area 
likely to have a great number of low SES respondents compared with areas such as 
Sandton and Braamfontein in Johannesburg. 
 
5.3.2 The influence of pharmacist’s age 
 
In this study, the dispenser was not always the pharmacist and it was agreed that the 
respondent pharmacist is accountable for what the patient would report. It came out that 
the pharmacist’s age may affect the outcomes in some cases. Table 32 shows that the 
younger pharmacists obtained higher rates about when the medication begins to work and 
its benefits (52.8% versus 37.1%); counseling points summarized (55.2% versus 36.2%) 
as well as doing the actual counseling (69% versus 54.6%). The meaning of age may be 
associated with the youth enthusiasm as well as to the academic training. Younger 
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pharmacists in SA have the benefit of intense refreshed pharmacology courses and 
modern pharmacy practice. There is then a need for continuing education on 
pharmacology and pharmacy practice for both the younger and older generations. 
 
Table 32 Testing impact of Age on counseling outcome measures 
 
Outcomes measures affected                                                                  Age scale  
 Young 
% 
Older 
% 
 
(p) 
When does the medication begin to work and benefits 52.8 37.1 0.04 
Counseling points summarized 55.5 36.2 0.01 
Dispenser did actual counseling on the medication offered 69.0 54.6 0.05 
 
5.3.3 The influence of Dispenser’s qualification  
 
As stated above, the method used to evaluate the extent to which counseling is carried out 
is based upon the performance of all categories of dispensers as a whole. A comparison 
test was necessary to investigate a possible bias when assigning the results to the 
pharmacist. In general, pharmacists would perform or behave much better than other 
categories of dispensers. For example, from table 33, 95.8% of pharmacists greeted 
patients and established comfort level whilst this achievement was on average 78.6% for 
pharmacist assistant, 69.2% for other staff member and 84.6% for the undefined 
dispenser (p ≤ 0.03).  
 
Table 33 Testing impact of Dispenser qualification on counseling outcome measures 
 
Outcomes measures affected                                       Dispensers identified 
 
Pharmacist 
 
 
% 
Assistant 
 
 
% 
Other 
staff 
member 
% 
Unknown 
 
 
% 
 
 
 
(p) 
Dispenser greeted patient and established 
comfort level 
95.8 78.6 69.2 84.6 0.03 
Dispenser tried to obtain initial drug related 
information 
67.1 34.7 58.3 30.0 0.05 
Dispenser introduced generics for 
substitution 
55.1 
 
14.8 
 
76.9 
 
30.8 
 
0.00 
 
Counseling points summarized 58.9 29.6 33.3 23.1 0.04 
 
  
 
47
6 QUANTITATIVE FINDING SUMMARIES DISCUSSION 
 
The table 34 below summarizes the main quantitative outcomes drawn from this study.  
 
Table 34: Quantitative study outcomes summaries 
 
Outcomes measures Outcomes trends  
 
Prevalence of counseling  
Any form of advice given to patients 95% 
Estimated mean percentage of patients verbally counseled  74 %  
Mean number of drug informational items achieved 6.1/10 
Mean number of pharmacist behavioural items completed 5.8/10 
Mean number of patients given on average 6 drug items 62% 
 
Format or method of counseling 
Verbal advice alone 46.7 % 
Verbal advice supported by written information 44.5 % 
Written advice as label on the packet or insert leaflet alone   8.8 % 
 
Model of communication 
Intensive dialogue (patient is asked to relate back the advice) 27 % 
 
Type and extent to which information is given 
Drug instructions for use > 70 % 
Side effects related advice < 50 % 
Storages conditions and disposal of unused medicines < 50 % 
Special precautions e.g. food, beverages, OTCs to be avoided < 50 % 
 
Predictor factors on counseling practices 
Pharmacy type, workload and gender No relationship well defined 
Location Johannesburg rates higher than Pretoria 
Age Younger performance higher than Older 
Dispenser qualification Pharmacist performs better than other dispensers 
 
Acceptability and Feasibility of self-assessment by pharmacist 
Acceptability 80 % 
Feasibility 72 % 
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The performance and extent of counseling events  
 
From Pharmacist-Self-Assessment (PSA), about 95% of pharmacists said they would 
counsel spontaneously each time they dispense any drug. However, when asked if the 
person who dispensed their medicines during the investigation day did give any 
medication-advice, about 74% of patients agreed and 26% disagreed. Thus, 95% rate 
given by pharmacists is indicative of the rate of counseling including any form of 
information. The 74% rate furnished by patients represents the trend of the actual verbal 
medication advice. 
 
The PSA study indicated that on average about 58% patients received at least one 
informational item while at least one behavioural item had been achieved in about 67% 
patients on daily basis. These values were validated by the corresponding achievement 
measured from PIA, which gave the range of about 62 ± 15%. Then, effective 
comprehensive counseling occurs in the range of 60 to 70%. 
 
Overall, these rates are comparable to figures reported in the international literature. 
Berger (2005) in Germany found that 95% of pharmacies gave advice to the pseudo 
customers but the information on appropriate self-medication was provided on at least 
one item in 74% of pseudo customer visits. The figure is also comparable to the study of 
Svarstad et al (2004) in USA that showed the rate of any kind of information-giving was 
63% all drugs combined. Another comparable rate is found in the study of Shani et al 
(2000) in Israel that concluded counseling by pharmacists occurs at a high rate (64.6% 
for any type of counseling).  
 
It is worth noting that the rate of the introduction of generics for substitution is between 
48 and 75%. The law on mandatory generic substitution would have positively influenced 
the premature switch from branded to generics in the private pharmacy sector. 
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The type of information often given 
 
Results from both two investigational methods (PIA, PSA) showed that only three items 
relating to drug information were well covered (>70%); these are directions for use, 
dosage regimen and duration of consumption as well as making it clear what the name, 
class and purpose of the medication is. The points not satisfactory achieved (<50%) are 
giving advice on missing a dose, non-pharmacological intervention, telling when the 
medicine begins to work and side effects.  
 
Information on side effects was generally small and if ever it was given, the pharmacist 
often focused on the kind of side effects, which could occur, and less often on the 
seriousness or duration of the side effects. This may be explained by the fact that it is not 
so easy to predict the duration of side effects which can vary from one person to the 
other. We suggested that the task can be lightened if the pharmacist documents 
counseling events to construct reference records. The behavioural items that were 
extensively achieved are thoroughly reviewing the script and greeting the patient. The 
points not well achieved were asking patient consent for counseling, obtaining initial 
drug information and summarizing counseling points.  
 
This finding is comparable with the finding of Svarstad et al (2004) in USA that reported 
most commonly mentioned items being drug name (60%) and directions for use (59%); 
adverse drug effects being discussed for 17%, 31%, and 37% of the amoxicillin, 
ibuprofen, and paroxetine prescriptions, respectively; while 2% to 16% of the shoppers 
were told when the medication would begin to work. 
 
The WHO GPP standards stipulate that the amount and type of information provided to 
the patient should vary based on the patients’ needs and practice setting, and will vary 
depending on the pharmacy clientele. Since most of the patients always visit the same 
pharmacy, it can explain why the pharmacists do not need to counsel the same patient 
about the same medication at each refill time.  
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The method in which counseling is carried out 
 
Both the pharmacists and the patients confirmed that the medication-advising is given 
orally and in written form. From pharmacist self report, it came out that supplemental 
written information (written form as handwritten label or instruction written on the 
packet) is not always given but some of the time in about 56% of cases. Less than 10% of 
patients leave the pharmacy with only the label put on the packet or the insert leaflet. 
 
Despite the fact that the quality and accuracy of information given in this study was not 
evaluated, the rates observed sound satisfactory. Dowse and Ehlers (2005) pointed out 
that the presence of pictograms is helpful to contribute positively to both the 
understanding of instructions and adherence.  
 
 
Model of verbal interaction and quality of information 
 
To assess the understanding of or the level of satisfaction with verbal counseling, the 
majority of pharmacists would just ask whether the patient understood or is satisfied. It 
also appeared that only 27 % of pharmacists would ask patients to relate the information 
back and about 30% of pharmacists failed to assess the satisfaction of their patients in 
their daily routine. One can wonder whether just asking patients if they understood what 
the pharmacist has said is monologue or dialogue interaction. This outcome shows that 
there is some kind of dialogue between pharmacists and their patients but a 
comprehensive exchange is limited to about 27% of encounters. Pharmacists should make 
any effort to lift the extent to which a comprehensive exchange is carried out to ensure 
SA pharmacists escape from the monologue model criticised by Rutter (2004) and others. 
 
 
Factors that may affect counseling achievement 
 
Even though statistics are not rigorous, the findings about the relationship between 
predictors and counseling outcomes are indicative of evidence for the reduction of 
counseling performance.  
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In general, the odd ratios could be reduced by the following factors: pharmacist lack of 
time, patient does not like to be counseled because he/she already knows about the 
medication, pharmacists who yet have never heard about SA GPP guidelines, difficulty to 
accomplish some special SA GPP guidelines related to disabled persons. Statistic trends 
showed pharmacist-lack of time overweighing patient-in hurry (50% versus 47.9%). It 
appears, however, that even though every pharmacist had enough time to counsel, the rate 
could hardly rise beyond 74% estimated in phase-II study because many patients do not 
need to be counseled. 
 
In particular, the environment of each city, Johannesburg and Pretoria, may influence the 
patient’s perceptions about the satisfaction with pharmacist’s performance in patient 
counseling. The observed influence of age can be related to the youth enthusiasm as well 
as to the academic training. Younger pharmacists in SA have been going on intense 
pharmacology courses and benefited from the new, modern pharmacy practice. The 
qualification of the dispenser is likely to influence the counseling profile but this 
necessitates further standardized studies to get more significance about.  
 
Feasibility of assessment surveys in community pharmacies in SA 
 
In the present study, two assessment techniques were tested: Pharmacist Self-Assessment 
(PSA) and Patient Interview Assessment (PIA).  As it has been shown, the results were 
well concordant in giving the profile of covertures, yet some differences were observed 
with regard to the percentage obtained. The values obtained from PIA were higher than 
found in PSA for the items badly achieved while they remained almost comparable for 
items well counseled. For example, the rate of reviewing the script thoroughly was 87% 
and 99% for PIA and PSA respectively while the rate of asking patient consent for 
counseling was 48% from PIA and 29.4% from PSA. Pharmacist responses could be 
validated against the patients’ responses in the respective pharmacies. 
 
More over, the outcomes from this study are comparable to the published data obtained 
elsewhere by means of pseudo-customer or mystery shopper approach. It is then clear 
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that the self-reported responses from pharmacists sound more objective than subjective 
and indicate that the PSA questionnaire used is valid to serve as a self-assessment tool. 
 
When planning further surveys in community pharmacies one might anticipate a 
participation rate not greater than 75% provided intensive sensitization had been made 
before. SAPC has set up a tool to do confidential assessment of the nature and extent of 
pharmaceutical services carried out in community pharmacies. Yet there is no report 
about the work and findings. 
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7 QUALITATIVE ANALYSIS OF THE OUTCOMES 
 
 
As anticipated in the methodology section, the qualitative analysis was based upon the 
respondents’ comments, remarks and suggestions recorded. Behaviours and attitudes had 
to be interpreted using constant-comparative analysis technique, which challenges the 
pharmacists and patients responses. Since there was no absolute mutual correspondence 
between every pharmacist and his/her customers, answers from pharmacists were 
gathered and then compared to patients’ outcomes where applicable. The contribution by 
all the participants revolves around the four themes below. 
 
7.1 ACCEPTABILITY AND FEASIBILITY OF THE ASSESSMENT 
   
 a)   Pharmacists’ attitude with regard to patient counseling  
 
During this survey, the majority of pharmacists showed a positive attitude with regard to 
patient counseling and gave me their full and spontaneous attention. Thereof, pharmacist 
assessment on patient counseling practice was rendered feasible. The comments and 
suggestions made by the participant pharmacists in the selected section of Gauteng 
portray the SA pharmacists’ attitude to the ease/difficulty of complying with the 
pharmacist’s new role. The new pharmacist is defined as someone who manages the 
totality of the illness of the whole person by dispensing, communicating, listening, and 
talking with patients.  
 
It is worth noting that some pharmacists agreed to participate but refused to allow 
interviews with their patients. The reason for reluctance or refusal of those pharmacists to 
enter the survey or to interview their patients must be deeply investigated. The fear of 
wrongdoing being reported may be anticipated as one. This will necessitate workshops 
aimed at clarifying the matter to ensure self-confidence and enthusiasm from the 
pharmacists.   
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b)   Patients’ attitude with regard to medication advising 
 
With regard to patients, I was surprised by their openness and high level of willingness to 
contribute to this research and swept away my previous fear of being aggressively 
received.  Many patients were interested enough to give their perception of counseling 
and information that they desired to be provided with. Moreover, the majority of patients 
asked further questions about their medication and showed interest in improving their 
knowledge following counseling by the pharmacist.  
 
7.2 PATIENTS’ PERCEPTION ON PHARMACIST’S COMPETENCES 
 
a) Patients’ attitude with regard to pharmacist’s behaviour   
 
Some patients made the following comments, 
 “There is excellent counseling in pharmacies. I make sure I always go to the 
same person and build up a personal relationship concerning my illnesses and 
complaints and medication. This interest is necessary I think for older patients 
who can feel very lonely and neglected.” 
 “I am very happy with the services I received. I think that SA should have 
more pharmacists like that pharmacist because she is very kind and sweet, she 
is very easy to talk to, someone who you can be open with.” 
 “I would like to deal with a friendly pharmacist who encourages the patients 
to come back the next time and would like to be treated equally with all other 
people.” 
 “Pharmacists must always be friendly and understanding towards the patient. 
Patience is also needed from them for patients to give them the respect they 
deserve.” 
 
According to patients’ view, most of the participant pharmacists seemed to be friendly, 
compassionate and empathic towards their patients, and counseled effectively and with 
competence. The concerns expressed throw light on patients’ needs to support their 
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efforts to develop medication management skills and to move in the direction of self-
responsibility.  Although many patients found pharmacists friendly, there were some 
patients complaining there were not treated in a friendly way compared to what it was 
observed by other people.  
 
b) Reliability of pharmacists as counselor   
 
Patients highly valued the counseling they received from pharmacists, and agreed they 
got the necessary knowledge regarding the use of their medication. However, some 
patients contended,  
 “The pharmacists are very nice but some of them do not really care about 
counseling.”  
 “Everyone working in a pharmacy, not only pharmacists should get simple basic 
skills on how to approach and talk to patients.” 
 
The background section pointed out that today, in every SA University where a pharmacy 
programme is offered, a course on Pharmacy Practice is included in the curriculum that 
involves teaching the practical applications, legal and ethical aspects, marketing and 
business skills. The outcomes from this survey showed that the level of pharmacists’ 
compliance with Pharmacy Council Regulations is high and the actual impact of 
academic changes is unquestionable. Thus, the observation made by those patients may 
be isolated or individual circumstances.  
 
Nevertheless, the community pharmacists should take up these challenges. Continuing 
professional education programmes are necessary to ensure every pharmacist 
comprehends the importance and the competence to carry pharmaceutical care out with 
empathy, sincerity and patience. 
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7.3 NATURE AND EXTENT OF COUNSELING PRACTICES 
 
a) The format of communication 
 
Patients frequently wanted both types of information, written or verbal counseling as 
expressed in the following statements:  
 “I would like the pharmacist to write the information on paper.”  
 “Sometimes, the leaflet is not in the box, although it would be of help to the 
patient if the leaflet is kept within the box.”  
 “Written information is not enough because not all people can read and others 
are ignorant, verbal info is good.”  
 “The pharmacist must give health education about the drug that a particular 
patient is going to take and should always be verbal in order to create the 
relationship with their patients.”  
 “It is important that pharmacists remain open to their patients, mostly when they 
are giving drugs to the patient.”  
 “If possible, the person who has given the drug should always indicate on the 
sticker the name and telephone number of the pharmacy so that if the patient has 
gotten any side effects, he/she can easily contact the pharmacy staff in time.”  
 “When giving medication, the dispenser has to give the patient directions 
verbally, because most of the time, they assume that the directions are already 
on the medication.” 
b) The nature and extent of counseling provided in daily routine 
 
Pharmacists themselves made recommendations such as:  
 “Pharmacist should give any other information, which may be considered 
necessary at the time, including life changes.”  
 “Pharmacist should provide patient with precautions e.g. what leads to 
drowsiness, what not to use while operating machinery or driving.”  
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 “It is important to mention and record interactions with other medicines being 
taken by patient.” 
 
These observations show that the participating pharmacists are conscious of the concern 
about adverse reactions and non-pharmacological information. Continuing self-education 
may contribute to filling the gap.  
 
Many patients interviewed stated that they received some written or verbal counseling, 
but did not receive all of the information they had desired. Patients’ particular cases are 
expressed as follow: 
 “I would like to know what consequences it will have if I do not follow exactly 
the prescription.” 
 “Pharmacist should always try to explain how medications given work and their 
reactions to patients.” 
 “I would like to know the danger if one product is consumed for several days. I 
wish to be told how long to take the medicine, what happens if the person is not 
cured after several days (what to do next). The most significant information 
needed is the danger of the product.” 
 “It’s pointless being sick and not knowing what is wrong, worse being given 
medicine that you don’t know with the hope that it’s the doctor that prescribes so 
the patient can’t question it. It has to be right to get some knowledge about drugs. 
This could help patient’s adherence.” 
 “I would like to have information about potential side effects and how medication 
bought would interact with other medication taken, if any.” 
 “I expect from pharmacist more information like if the medication causes 
dizziness.”  
 “The pharmacists should counsel to stress importance of adherence to drugs to the 
patient.” 
 “The dispenser was supposed to give warning about consuming other drugs 
simultaneously.” 
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 “I would like to know the purpose for the medicine, and how it will affect the 
body internally or externally. Also would like to know if any allergens are 
consisted in the medicine.”  
 “Patient should be given advice and good care.”  
 “I would like to know side effect warnings and the use of medication to avoid 
resistance to drugs.” 
 “Pharmacists must tell the patient about the side effects so that the person must be 
ready for every thing.” 
 “The pills were written  ‘take once a day’ but I was confused whether it should be 
anytime of the day or a specific time” 
 “Patients should be given options and advice, which are reasonable and effective 
alternative medications.” 
 
In general, the topics most often missed were storage instructions, interactions with OTC 
medications, instructions for a missed dose, and methods to avoid adverse effects and 
drug-interactions. There has been concern reported that providing information on adverse 
effects may prompt patients to report spurious reactions and reduce compliance (Burk 
ML 1998).  This has not been found to be the case in clinical trials. The Gibbs et al. 
(1989) study found that patients who received medication leaflets had greater recall of 
possible adverse effects and improved compliance more than control, with no increase in 
false reports of adverse reactions. However, as suggested by Gibbs et al (1989), all 
medication information is necessary but careful consideration should be given to how 
information on adverse effects is presented. 
c) Achievement of counseling process steps in daily routine 
 
Some pharmacists made the following statements: 
 “The general procedure with every patient should be the same. Care should be 
taken to ensure all the necessary measures are followed to assure effective and 
safe use of medication; this also includes important situations like repeat 
prescriptions.” 
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 “During the counseling session, the counseling points summarized seems to be 
difficult, so I suggest that each topic has to be summarized immediately when it is 
presented.”  
 “It is important to mention and record interactions with other medicines being 
taken by patient.” 
 
The GPP emphasizes that a pharmacist must counsel each patient or caregiver on matters, 
which will optimize the medical therapy prescribed. In addition, the interaction 
pharmacist-patient should be friendly and conducted in a one-to-one fashion.  One cannot 
discard the process of gradually summarizing the counseling points stated by one 
pharmacist, but it needs to be validated. Another pharmacist lifted the importance to 
mention and record interactions with other medicines being taken by the patient. GPP 
standards recommend the counseling session should be documented; any follow-up 
required should be noted; it should also be recorded if the patient does not wish to be 
counseled. Pharmacists are aware of the requirement but how many of them follow up 
with this? 
 
One patient said that her husband is a doctor, so she does not “really go through the 
whole procedure of counseling”. Such an attitude may limit the process to be completely 
achieved.    
d) Patients who should be always counseled 
 
This research showed some categories of patients on chronic therapies who expressed the 
need to receive more information. Examples are,  
 One 49-year patient on chronic medication (anticoagulant) saying, “I need to 
know how this medication works in interaction with others to be on the safe side. 
I would like to know what are the generics and substitutions”. 
 An orthopaedic patient in clinic who contended, “I normally get medicine without 
knowing the name of the medicine.” 
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 One patient in cancer-ward saying, “Sometimes the leaflet is not in the box, 
although it would be of help to the patient if the leaflet in the box is kept within 
the box.” 
 One patient who contended, “It’s very important to get counseling before one 
receives medication e.g. in terms of contraceptives, not everyone knows what 
kind of medications to avoid (drug interactions with drugs, with food, with 
disease state.” 
 
According to GPP, if the pharmacist cannot counsel everybody, it should be defined 
which patient types, or which medications pharmacist will routinely counsel patients. 
This will vary depending on the pharmacy patientele and may include patients receiving 
more than a specified number of medications; patients known to have visual, hearing or 
literacy problems; paediatric patients and patients on anticoagulants. Patients who are 
prescribed long-term medications need to understand the serious effects that chronic 
illness has on their lifestyle.  
 
7.4 FACTORS INFLUENCING COUNSELING PRACTICE 
 
a) Resource scarcity and lack of time 
 
One patient contended, “The pharmacists and pharmacy staff in general are in such a 
hurry to let a patient go, they don’t even give him/her enough time to express his/her 
problem and ask questions about the medication. The patient has no choice and has to go 
just after paying the product.” 
 
 “More awareness should be raised in the public that we are not a ‘fast-food’ outlet and 
need time to assess and dispense prescriptions”, contended one pharmacist. 
 
The study showed that in the 60 pharmacies investigated, there were 22 pharmacist 
assistants, 6 pharmacist interns and 4 other staff members acting as dispensers. Some 
pharmacists said there is a need of more pharmacists and less pharmacist assistants. Once 
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more, a debate is opened about resource scarcity in profession. Whether it is time or 
money, no business ever has enough and pharmacy is no exception. Due to the shortage 
of work force, the main function of many pharmacists in the practice settings remains that 
of dispensing, and this trend is reflected elsewhere in the world. The fact that many South 
African pharmacists function both as dispensers of medications and as pharmaceutical 
care practitioners in community pharmacy environments may be a factor contributing to 
the increasing number of dispensing errors reported to the SAPC (Kairuz and Naidoo 
2005). 
 
Despite that evidence, the standards underline that the health care professional’s 
responsibility is to support the person’s efforts to develop medication management skills 
and to move in the direction of self-responsibility with empathy, sincerity and patience. 
b) Counseling area and confidentiality 
 
One pharmacist said, “There is a need to educate patients to have more respect for what 
the pharmacist has to say to the person in front of you in the queue.” Another added, “It is 
important to have a counseling room so that interruption will be minimized.”  
 
Not almost all the community pharmacies visited except some clinic settings have special 
counseling rooms. On this matter, GPP recommends the patient should be counseled in a 
semi-private or private area away from other people and distractions, depending on the 
medication(s). That provides an opportunity for patients to ask questions they may be 
hesitant to ask in public. The necessity of private counseling area still holds in SA. 
c) Knowledge and applicability of SA GPP standards 
 
One of the study guide questions was “Are the national standard scenarios on counseling 
sufficient and well known by the pharmacists?” Some pharmacists, as additional 
contribution to improve the current SA GPP guidelines, mentioned the following 
suggestions:  
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 “Pharmacists wish some protocol to help impairment person. What are they 
supposed to do and what are they protected for?” 
 “Pharmacists need a specific dosage indication from psychiatric doctors.” 
 “Make it mandatory for manufacturers to include patient ‘friendly’ leaflets in 
African language as well as English.”  
 “Pharmacist Assistant and other Pharmacy Staff member may be responsible for 
all, depending on scheduling.” 
 
As earlier reported in the quantitative section above, there were yet some pharmacists 
who are not informed about the GPP guidelines on patient counseling. In trying to know 
why patients are not asked for their consent for counseling, one of the pharmacists 
interviewed said, “In SA, pharmacists feel that they don’t need to ask patient consent for 
counseling, it is their duty”. The remark sounds pertinent but it does not leave the patient 
a decision-maker of his/her own course of therapy as recommended by GPP standards.  
These suggestions also showed that GPP guidelines for physical or mental impairment 
have to be reviewed or well documented for the attention of some dispensers.  
 
In USA, the OBRA 90’ mandates pharmacists to offer counseling to patients. The result 
of this policy showed that pharmacists increased communication with patients and other 
health care professionals and the outcomes of drug therapies improved among targeted 
patient groups. In SA, even though yet there is no coercive law provisions on Patient 
Counseling, there are sufficient incentive Gold Standards. For instance, dispensed 
medicine should be labelled as required in Regulation 8(4) of Act 101 of 1965.  Is this 
sufficient or should the authority move forwards? 
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8 CONCLUSIONS AND RECOMMENDATIONS 
 
 
8.1 LIMITATIONS 
 
No study is without its imperfections. Although an attempt has been made to isolate as 
much as possible relative bias and to draw a conclusion regarding the current nature and 
extent of counseling in the community pharmacies of South Africa, precise conclusions 
cannot be drawn, given the complexity of the issue under investigation. The present study 
had a number of limitations that illustrate the two cases below.  
 
First, data were collected from 60 community pharmacies including independent owned, 
chain, linked settings and clinic pharmacies in two cities, Johannesburg and Pretoria. 
While this distribution of pharmacy types is consistent with national data, one cannot 
generalize to other cities nationwide.  
 
Second, even though objective validated measures of counseling were considered, it was 
not possible to control all variables that likely influence counseling practices. The 
multivariate nature of the study allows many factors, other than pharmacy and pharmacist 
characteristics, to have had an effect. For example, any respondent’s psychological or 
antecedent situation may affect the truth of the response given. 
 
8.2 CONCLUSIONS 
 
Although the statistical analysis of the results is not yet complete, some relative 
conclusions can already be drawn. The major finding of this study is that both 
pharmacists and patients highly valued the extent of counseling they gave or received.  
 
The results indicated that patient counseling exists in the section of Gauteng’s community 
pharmacies studied and occurs at high rate (60 to 74%) comparable to figures found in 
the international literature.  
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Pharmacists give both verbal advice and written information to good satisfaction of the 
majority of their patients. Patients have a strong desire to receive both written and verbal 
drug information. However, apparently now, patients and pharmacists agree that the 
majority of drug insert leaflets need improvement to satisfy registration requirements. 
 
The counseling given concentrates mainly on drug-instructions for use, while information 
about drug action and side effects seems to be less common. Yet in general, patients’ 
surveys reveal that they are interested in drug effects and side effects, besides their 
interests in how to use their drugs.  
 
The South African community pharmacists have good knowledge of Gold Standards on 
counseling and perform well in the application of the SA GPP guidelines, yet a small 
number ignore the existence of SA GPP guidelines.  
 
Apart from setting up the shape of the actual counseling practice, this study is a 
contribution to the continuing professional education since the items developed in the 
questionnaire allowed the participant pharmacists to recall on basic provisions embodied 
in the GPP Guidelines.  
 
There is scope for improvement in pharmacists’ behaviour with respect to asking patients 
consent for counseling; this will give patients the power to direct their own course to 
good understanding of medication benefits.  
 
It is worth noting that some pharmacists agreed to participate but refused to allow 
interviews with their patients. The reason for reluctance or refusal of some pharmacists to 
enter the survey or to interview their patients must be deeply investigated.  
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8.3 RECOMMENDATIONS 
 
To ensure that pharmacies’ performance in South Africa is beyond reproach, the SA 
Medicine Control Council (MCC) and SA Pharmacy Council should embark upon The 
Mandatory Provision with GPP Standards on patient counseling. 
 
There is a need to mandate drug manufacturers to include ‘patient-friendly’ leaflets in 
African languages as well as English.  
 
There is also a need for establishing protocols aimed to gather the necessary information 
from the customer, process this information and provide the customer with the correct 
advice and further information if necessary. 
 
This will necessitate workshops aimed at clarifying the matter to ensure self-confidence 
and enthusiasm from the pharmacists. In such a changing and increasingly complex 
profession like pharmacy, the need for continuing professional education is evident. 
 
Future studies should gather further evidence on the implementation of patient counseling 
from a nationwide sample. The future initiatives will clarify why some pharmacists 
hesitate to enter the survey or to interview their patients. The impact of SES, race, 
religious believes as well as differences in pharmacy curricula and experiential training 
might enable to better understand the trends uncovered in this study.   
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APPENDIX 1: Pharmacist Self-Assessment Instrument 
 
Pharmacist Informed Leaflet 
 
Dear Pharmacist, 
 
I am a Masters student at the University of The Witwatersrand and I am conducting a 
survey as part of my research to fulfill the academic requirements of the Master’s degree 
in Pharmaceutical Affairs (Msc Med). 
I would appreciate your cooperation and participation in this study. 
 
The purpose of the survey is to assess whether and to what extent patients are counseled 
on their medication by dispensing pharmacists in community pharmacies and private 
pharmacies. 
 
It is important for me to learn more about what YOU do in terms of PATIENT 
COUNSELING AND ASCERTAIN YOUR OPINIONS ON SOME OF THE MAJOR 
ISSUES CONCERNING THIS IMPORTANT ELEMENT OF PATIENT CARE. 
 
The pharmacy for which you are responsible has been randomly selected from the 
PHARMACY INFO GUIDE the related database-open in 2003, the latest up to today, as 
one of the participants for this survey. As a respondent, YOUR opinions and YOUR 
answers are extremely important in making the results of this study statistically valid. 
Please note that there are no wrong and right answers. 
 
I would greatly appreciate if you could take some few minutes of your time to complete 
the attached questionnaire. It will be of great help if you could answer as honestly and as 
accurately as possible. This will hopefully, enable me to produce a worthwhile study that 
can be of benefit to health care policy in South Africa. 
 
You can be assured that the responses obtained shall remain strictly confidential. 
This information will be used for publication of article and thesis. Any details or 
information that identifies you or your pharmacy will be withheld from publication. 
 
Your participation is strictly voluntary and your right to refuse to participate will be 
respected. If you have any queries, please feel free to contact me or the ethics committee 
of the University of the Witwatersrand, Johannesburg at contact details listed below. 
 
Thanking you 
Yours Sincerely 
Monique Rwabuhungu 
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Pharmacist Informed Consent Form 
 
 
I have fully understood the above information about this study, which I have read. 
I understand what will be required of me if I take part in the study. 
 
My questions concerning this study have been answered by  
 
........................................................................................................................ 
      (name of research representative) 
 
 
I agree to take part in this study: Yes / No (answer to be circled) 
 
I understand that I may withdraw from the study at any time without giving a reason and 
without affecting my normal care and management. 
 
 
Yes / No (answer to be circled) 
 
 
Participant's signature: ...........................................   Date: .............................. 
 
Investigator’s signature: .........................................   Date: .............................. 
 
Investigator name: ......................................................................................... 
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Pharmacist Questionnaire 
 
SURVEY ON PATIENT COUNSELING IN COMMUNITY PHARMACY  
 
PHARMACIST SELF-ASSESSMENT QUESTIONNAIRE 
 
Objectives of the survey include to: 
• Ensure the awareness of Gold Standards of counseling provided by Pharmacy 
Council 
• Identify the frequency with which counseling is carried out. 
• Rate the perceived importance of any information given. 
• Rate the ease/difficulty of carrying out the counseling. 
 
For administration use only be complete by the researcher 
PHARMACY CHARACTERISTICS 
 
Date: ------                     
Pharmacy identification and type: Code number  ----       
Dispenser of medication:------- 
Approximate age of the Pharmacist:  young (<35)----  old (>35) ---- Gender: M—F--- 
Workload level: 1---, 2---- 3---- 
 
Directions 
 
Base your assessments on observations made during the dispensing process. For each 
step choose the relevant statements as is appropriate.  
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1. Current nature and extent of counseling 
  
 1.1. Who is responsible for dispensing medication in your pharmacy? 
 
 Pharmacist  
 Pharmacist Intern  
 Pharmacist Assistant 
 Other Pharmacy Staff member  
 
1.2. How often do you give counseling to your patient?  
 
 Spontaneously each time I dispense any drug  
 Only for prescribed drugs  
 When if the patient seeks information  
 
1.3. What kind of information do you often give to your patient?  
 
 How to take the medicine  
 How to store the medicine  
 Anticipated adverse reactions associated with the medicines  
 Contra-indications of medication  
 Other: specify……………………………………………  
 
1.4. What other information do you include with the medication? 
 
 What is the therapeutic objective of the medication  
 What symptoms will disappear and what symptoms will persist 
 How long before the medication takes effect 
 What can happen if the medication is not properly or not used at all   
 
1.5. Which information concerning side effects do you always mention to the patient? 
 
 What kind of side effects may occur   
 How to recognize them  
 For how long they persist  
 What is the level of seriousness  
 What intervention can patients take to alleviate side effects 
  
1.6. Which of the following instructions with regard to use is necessary to mention on  
       each patient visit? 
 
 How to take the medication 
 How long should the medication be taken  
 How should the medication be stored  
 What to do with the unused medicine at the end of the treatment 
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 When not to take the medication 
 What is the maximal dose 
 Why the medication should be taken in whole course 
 What to do if the medicine is lost or spoiled 
 In what case to consult the doctor or the pharmacist before a next appointment  
 
      1.7. How often do you give supplement written information? 
 
 Always   
 Some of the time  
 Only if the leaflet is not provided with the medicine  
 Only if the patient is a hearing-impaired 
 If the patient asks for it 
       
      1.8. How do you assess the understanding of the patient?  
 
 I question patient 
 I ask them if they understood my counseling  
 I ask them to relate the information back to me 
       
      1.9. How do you assess patients’ satisfaction with your counseling? 
 
 I ask them   
 I run surveys 
 I have a feedback box in the pharmacy 
 None of the above  
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2. Feasibility of counseling in your daily routine  
 
This is to assess whether any of the events mentioned occur.  
 
With reference to your last 5 patients, in how many patients did you accomplish the 
following items? 
(0 = none; 1=one patient; 2=two patients; 3=three patients; 4=four patients; 5=five 
patients). 
 
 
 
 
The following Drug information items were given to the patient 
 
Score 
0 – 5 
1.□Name, □class and □purpose of medication  
 
2.□Dosage regimen and □duration of consumption  
 
3.□Advise on missing a dose 
 
4.□Side effect profile (management and prevention) 
 
5.□Drug interactions with other drugs, □with food, □with disease state 
 
6.□Precautions to be aware of 
 
7.□Directions for use 
 
8.□Storage recommendations 
 
9.□When does the medication begin to work and benefits 
 
10.□Non-pharmacological Intervention 
 
 
Pharmacist behavioural Items  
 
0 - 5 
1.  □Dispenser greeted patient and established comfort level  
 
2.  □Dispenser reviewed the script thoroughly  
 
3.  □Dispenser asked patient a consent for counseling  
 
4.  □Dispenser tried to obtain initial drug related information  
 
5.  □Dispenser introduced generics for substitution  
 
6.  □Dispenser did actual counseling on the medication offered 
 
7.  □ Warning about consuming other drugs simultaneously given 
 
8.  □Clarification of any uncertainties/ confirmation patients understanding of current 
therapy 
 
9.  □Counseling points summarized 
 
10.  □ Patient invited back 
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3. Communication Barriers  
 
Give a relative impact of each factor on your communication with patients 
Give a relative estimation (25% =1;   50%=2;   75%=3;   100%=4)  
 
3.1. Pharmacist related barrier 
 
 Lack of time,  
 Lack of staff, 
 Distractions (noise, phone call, etc)  
 Lack of experience with patient-counseling 
 
3.2. Patient related barrier 
 
 Patients are in hurry 
 Patients request not to be counseled because they already know about the 
medication 
 Patients have hearing or language problem 
 Patients have elderly-related cognitive problem 
 
4. Knowledge of Gold Standards on counseling established by the SAPC 
 
Give a relative estimation in difficulty to accomplish the following recommendations 
of GPP   (0%= 0;   25%=1;   50%=2;   75%=3;   100%=4). 
 
4.1. General considerations in communicating with the patient 
 
 Treating the patient well with respect and interest, and be friendly, caring, and 
willing to help 
 Having adequate and correct knowledge about the subject under discussion 
 To be relaxed and attentive by maintaining eye contact with patient 
 Being sensitive towards the patients need for privacy and confidentiality 
 Asking open-ended questions and listening and observing without interrupting. 
 
4.2. Special considerations in communicating with the elderly 
 
 Focus on their abilities, rather than disabilities. 
 Assess them individually and reassess often.  
 If they are unable to give information, use family or caregivers as resources. 
 Need to ensure that the disabled should have easy access and seating.  
 
 
4.3. Alternative approaches based on special need for the hearing impaired 
 
 Eliminate as much background noise as possible 
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 Augment oral communication with other methods (writing, pictures, signs and 
gestures)  
 Face the person directly to achieve eye contact and enable lip reading, speak 
slowly and clearly without shouting, and avoid unnecessary detail 
 
4.4. Alternative approaches based on special need for the visually impairment 
 
 Take position what needs attention so it’s at the centre of the visual field 
 For printed communication, use black printing with larger fronts on white paper 
 
 4.5. Alternative approaches based on special need for the cognitive impairment 
 
 Gain the patient’s attention, and address one topic at time by giving simple and 
relevant information 
 Upgrade the patient communication facilities (e.g. counseling booths) 
 
 
5. Additional information 
        
5.1. Do you have a copy of SA GPP in your pharmacy? 
 
* Yes 
 
* No 
 
5.2. If no, what is the reason? 
 
……… 
 
 
5.3. Give any suggestion to improve the process of counseling or any additional 
guideline to insert in the current SA GPP guidelines 
……… 
 
 
 
 
THANK YOU FOR YOUR CONTRIBUTION 
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APPENDIX 2: Patient Interview Assessment Instrument 
 
Patient Informed leaflet 
 
Dear Sir, Madam, Miss, 
 
I am a Masters student at the University of The Witwatersrand and I am conducting a 
survey as part of my research to fulfill the academic requirements of the Master’s degree 
in Pharmaceutical Affairs ( Msc Med). 
 
I would appreciate your cooperation and participation in this study. 
 
The purpose of the survey is to assess whether and to what extent patients are counseled 
on their medication by dispensing pharmacists in community pharmacies. 
 
It is important for me to learn more about what OUR pharmacists do in terms of 
PATIENT COUNSELING AND ASCERTAIN YOUR OPINIONS ON SOME OF THE 
MAJOR ISSUES CONCERNING THIS IMPORTANT ELEMENT OF PATIENT 
CARE. 
 
You have been randomly selected among the patients of this pharmacy as one of the 
participants for my survey. As a respondent, YOUR opinions and YOUR answers are 
extremely important in making the results of this study statistically valid. Please note that 
there are no wrong and right answers. 
 
I would greatly appreciate if you could take some few minutes of your time to complete 
the attached questionnaire.  
 
It will be of great help if you could answer as honestly and as accurately as possible. This 
will hopefully, enable me to produce a worthwhile study that can benefit to health care 
policy in South Africa. 
 
You can be assured that the responses obtained shall remain strictly confidential. Any 
details or information that identifies you will be withheld from article and thesis 
publication. 
 
Your participation is strictly voluntary and your right to refuse to participate will be 
respected. 
 
Thanking you. 
Yours Sincerely 
Monique Rwabuhungu 
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Patient Informed Consent Form 
 
 
Participation in a research study 
 
By signing this form, you are consenting to participate in a research study. 
 
Consent: 
 
a. I have read the description of the research study as outlined above. The 
study representative has explained the study to me and has answered all of 
the questions I have at this time. 
b. I freely volunteer to participate in this study. I understand that I do not 
have to take part in this study and that my refusal to participate will 
involve no penalty or loss of rights to which I am entitled. 
 
 
Name of Participant: _________________________________ 
 
Signature:  
                                                 Date: ______________ 
 
 
Name of person obtaining Consent: __________________________ 
 
Signature:  
 
                                                Date: ________________ 
 
 
 
Contacts: 
Principal Researcher 
Monique Rwabuhungu 
E-mail: rwabumon@yahoo.com 
Cell: 073 581 3840 
 
Human Research Ethics Committee (Medical) 
Chair Person: Professor PE Cleaton Jones 
Secretary: Ms Anisa Keshav 
E-mail: keshava@research.wits.ac.za 
Tel: 717-1234 
Fax: 339-5708 
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Directions 
 
 Base your assessments on observations made during the dispensing process. For each 
step choose the relevant statements as is appropriate. 
 
For administration use only- be completed by the researcher 
PHARMACY CHARACTERISTICS 
 
Date: ------                    Time:------ 
Pharmacy identification and type: Code number  ----       
Dispenser of medication:------- 
Approximate age of the Pharmacist:  young-----old ----     Gender: M------F 
Workload level: 1---, 2---- 3---- 
Prescription(s) :  
 
Pharmacist Questionnaire 
 
 
Questions 
 
1. How often do you get your medicines in this pharmacy? 
 Always  
 Frequently  
 Rarely  
 This is the first time  
 
2. Who dispensed your prescription? 
 The Pharmacist 
 The Pharmacist Assistant 
 The pharmacist Intern 
 Other staff member 
 I don’t know 
 
     3. Did the Pharmacist/person helping you give you any counseling about your  
        medications? 
 Yes 
 No 
 
4. If you received counseling, what was the method in which it was given to you? 
 Written form as a printed label on the packet  
 Written information on a leaflet 
 Verbal advice 
 Both written and verbal advice  
5. If verbal advice was given, how were you satisfied with the counseling you  
    received from your pharmacist? 
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 Very satisfied  
 Fairly satisfied 
 Neither satisfied nor dissatisfied 
 Not very satisfied 
 Not satisfied 
 
     6. If you felt important information was not provided. 
         Please specify what you would have liked to know: 
         …………………………………………………………………………………. 
         …………………………………………………………………………………. 
         …………………………………………………………………………………. 
 
7. Describe whether the dispenser mentioned one or more informational topics in the 
following table 
 
Drug information items  No 
=0 
Yes 
=1 
1.□Name, □class and □purpose of medication  
  
2.□Dosage regimen and □duration of consumption  
  
3.□Advise on missing a dose 
  
4.□Side effect profile (management and prevention) 
  
5.□Drug interactions with other drugs, □with food, □with disease state 
  
6.□Precautions to be aware of 
  
7.□Directions for use 
  
8.□Storage recommendations 
  
9.□When does the medication begin to work and benefits 
  
10.□Non-pharmacological Intervention 
  
 
Pharmacist behavioural Items  
 
No 
=0 
 
Yes 
=1 
1.  □Dispenser greeted patient and established comfort level  
  
2.  □Dispenser reviewed the script thoroughly  
  
3.  □Dispenser asked patient a consent for counseling  
  
4.  □Dispenser tried to obtain initial drug related information  
  
5.  □Dispenser introduced generics for substitution  
  
6.  □Dispenser did actual counseling on the medication offered 
  
7.  □ Warning about consuming other drugs simultaneously given 
  
8.  □Clarification of any uncertainties /confirmation patients understanding of current 
therapy 
  
9.  □Counseling points summarized 
  
10.  □ Patient invited back 
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3. Do you have any comments or suggestion about the counseling you received 
or would like to receive? 
 
………………………………………………………………………………………
………………………………………………………………………………………
………………………………………………………………………………………
………………………………………………………………………………………
………………………………………………………………………………………
………………………………………………………………………………………
.. 
 
 
 
 
 
 
 
THANK YOU FOR YOUR CONTRIBUTION 
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